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Nitric Oxide Production: A Mechanism for Inhibition of
Chlamydia trachomatis Replication
by
Bojun Chen
Chlamydia trachomatis (CT) replicates in macrophages, but is inhibited by
IFN-y or LPS. IFN-y and/or LPS induced nitrite production in mouse peritoneal
macrophages, macrophage cell lines (RAW264.7 and J774A.1) and McCoy cells.
Kinetic studies indicated that peak production occurred 48 hours post-treatment. CT
infection itself was insufficient to induce nitrite production, but resulted in
enhancement o f nitrite production in IFN-y-treated cells. Treatment with IFN-y or
LPS resulted in significant inhibition of CT replication in these cells. Strong
correlation between nitrite production and inhibition of CT replication was observed
in RAW264.7 and J774A.1 cells (correlation coefficients: -0.93 and -0.94, p< 0 .0 0 1 ),
N(-monomethyl-L-arginine (L-NMMA) specifically inhibited nitrite production and
partially reversed inhibition of CT replication in macrophage cell lines. NOS mRNA
was measured in RAW264.7 cells by Northern blot and Dot blot hybridization. Strong
correlation between NOS mRNA expression and inhibition o f CT replication
(correlation coefficient: -0.97, p < 0 .0 5 ) was observed. Anti-TNF-a antibody
completely neutralized the biological activity o f TN F-a secreted by LPS-treated
RAW264.7 cells, yet the antibody neither reduced nitrite production nor restored CT
replication. Combination of the antibody and L-NMMA significantly enhanced
restoration o f CT replication. In peritoneal macrophages, inhibition o f CT replication
induced by IFN-y was partially restored by L-NMMA or anti-TNF-a antibody. In
McCoy cells, inhibition of CT replication induced by IFN-y and LPS was not
significantly restored by L-NMMA. Great restoration o f CT replication by 1 mM LNMMA was observed in LPS-treated J774A.1 cells (31%), but not in IFN-y-treated
cells (5%). Our data indicate that (1) NO production is one o f the mechanisms for
inhibition o f CT replication in IFN-y-activated peritoneal macrophages and
RAW264.7 cells; (2) NO plays a significant role in CT inhibition in LPS-treated
macrophage cell lines, but not peritoneal macrophages; (3) T N F-a may be associated
with inhibition, but the mechanism(s) may not involve NO production; (4) NO
production may not be the mechanism for CT inhibition in McCoy cells treated with
IFN-y and LPS.
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CHAPTER 1
Introduction

Epidemiology o f Chlamydial Genital Infection
Chlamydia trachomatis (CT) is a major cause o f sexually transmitted disease
with more than 4,000,000 new cases diagnosed annually in the United States (CDC
1985, Holmes 1981, Schachter 1978). Genital CT infection in men can cause
urethritis which accounts for 50-60% o f nongonococcal urethritis (Bowie 1984, Thelin
et al. 1980). Genital CT infection in women can progress to serious diseases such as
mucopurulent cervicitis, acute pelvic inflammatory disease, peritonitis, perihepatitis
and salpingitis. Although 60-70% o f the women were clinically asymptomatic at the
time o f diagnosis (Campbell and Dodson 1990, Lipkin et al. 1986, CDC 1985),
genital CT infection can result in ectopic pregnancy and tubal infertility (Chow et al.
1990, Henry-Suchet 1988, Walters et al. 1988). Infants delivered from infected
mothers have a high incidence o f inclusion conjunctivitis and pneumonia (Schaefer et
al. 1985).

General Characteristics of Chlamvdia trachomatis
CT is a species of the genus Chlamydia which includes two other species:
Chlamydia psittaci and Chlamydia pneumoniae (Mardh 1989). Although the degree o f
genomic DNA relatedness among the three species is low (ranging from less than
10% to almost 30%, Mamat et al 1992), they share many biological and biochemical
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properties such as obligate intracellular multiplication, an unique developmental cycle,
LPS and inclusion formation in infected host cells. They also can be differentiated on
the basis of inclusion type and sensitivity to sulfonamides. CT inclusions contain
glycogen whereas C. psitfaci and C. pneumoniae do not. CT is more sensitive to
sulfonamides than the others (Mardh 1989). Moreover, CT can be subdivided into
three biovars: trachoma, lymphogranuloma venereum (LGV) and mouse pneumonitis
(MoPn). The biovar trachoma consists o f 14 serovars (A-K, Ba, Da and la). The
serovars A, B, Ba and C are associated with endemic trachoma, a leading cause of
preventable blindness in the world. The remainder are primarily associated with
genital and neonatal infection (Freeman 1985, Wang and Grayston 1991). Four
serovars (L I, L2, L2a and L3) in the biovar LGV cause lymphogranuloma venereum
in tropical or subtropical areas as well as in the United States (Schachter 1978). MoPn
generally causes pneumonia in mice, but has been used in animats as a model for
genital CT infection (Rank et al. 1985).
CT is a small, gram-negative eubacterium (Weisburg et al. 1986), containing
chromosomal and plasmid DNA as well as 21S, 16S and 4S rRNA (Newhall 1988).
Because o f its small genome (600-850 kilobase pairs), CT can not encode all enzymes
necessary to generate ATP, and is entirely dependent upon host cells for energy
(Moulder 1988, Becker 1978). As other gram-negative bacteria, CT contains
lipopolysaccharide (LPS) which consists o f the typical components o f enterobacterial
LPS (Hearn and McNavv 1991). However, the endotoxin o f chlamydial LPS seems to
be much less active than that of gram-negative enterobacteria (Leinonen 1992).
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Chlamydial LPS has been found in lysosomes and on the surface of the plasma
membrane o f infected cells (Hearn and McNabb 1991).

Developmental Cvcle o f CT
CT has a unique developmental cycle involving alternation between two forms:
the elementary body (EB) and the reticulate body (RB). The EB, an infectious particle
(400-600 nm in diameter) is adapted to extracellular survival, whereas the RB, a
metabolically active particle (800*1200 nm in diameter) is a labile, noninfectious form
that exists only intracellularly. Both EBs and RBs contain approximately equal
amounts of a major outer membrane protein (MOMP) with a molecular mass of about
40 kDa. However, EBs have lesser amounts o f the 13, 59 and 62 kDa outer
membrane proteins, but have a cysteine-rich 60-kDa outer membrane protein which is
not found in RBs (Moulder 1991, Newhall 1987, Hatch 1988, Hatch et al. 1984). EBs
also have a greater extent o f disulfide bond cross-linking than RBs (Hatch et al. 1984)
and a dense nucleus at an eccentric region (Matsumoto 1988).
The chlamydial growth cycle is initiated by the adherence o f the EB to host
cells as shown in Figure 1. After attachment, the EB enters the host cell by receptormediated endocytosis (Hodinka et al. 1988, Wyrick et al, 1989). The endosome,
which develops into a inclusion, exists in the cytoplasm, escaping from fusion with
lysosome (Moulder 1991). In the endosome, the EB reorganizes into an RB which
begins to divide by binary fission. Within 18 to 24 hours after attachment, RBs begin
to undergo maturation culminating in the formation o f EBs. Approximately 40-48
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Figure 1
Sketch o f the Developmental Cycle o f Chlamydia.

EB=elementary body
RB=reticulate body
EB •
RB ©

&
hr
attachment
phagocytosis
0

m

> 4 8 hr
-lysis o f host cell
-release o f EBs
-exocytosis o f inclusion
-latent infection

hr
DNA, RNA,
protein synthesis
started
8

hr
reorganization
(E B -^R B )
12

multiplication by ^
binary fission

30 hr
reorganization (RB->EB)
infectivity increases

hr
inclusion formed

20

hours after attachment, EBs are released from the host cells by lysis o f the cells or by
some form of exocytosis from the host cells (Ward 1988, Todd and Caldwell 1985).
Nutritional depletion, pH modification, penicillin treatment or host defense
mechanisms affect the growth cycle (Moulder 1991, Mardh 1989).
According to the growth cycle, recovery o f infectious CT (EBs) decreases up
to 24 hr post-inoculation (pi), then increases after 48 hr pi. Therefore, CT replication
can be determined by kinetics of CT recovery,

immune Responses to ChlamvdiaUnfeclion
Chlamydial infection in humans elicits both humoral and cellular immune
responses (Wang et al. 1982, Brunham et al. 1981). Since details o f the humoral and
cellular immune responses in human infection are difficult to discern (Qvigstad et al.
1985), the precise roles o f the antibody, T cells, macrophages and cytokines remain
poorly understood. However, evidence from studies using animal models o f
chlamydial infection and in vitro cell culture systems, together with epidemiological,
serological and clinical observations of human chlamydial infections provide some
insight into the human immune response to chlamydial infection.
In culture, CT (biovar trachoma or LGV) and C. psittaci have been shown to
stimulate purified human or mouse B lymphocytes to proliferate and produce
polyclonal antibodies (Bard ct al. 1984, Levitt et al. 1986). Stimulated human B cells
require T-cell help for antibody production, while mouse cells do not. The B cellstimulating factor may not be chlamydial LPS, since (a) polymyxin B failed to inhibit
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Chlamydia-induced polyclonal B cell activation and (b) C3H/HeJ mice (LPSnonresponders) responded normally to Chlamydia with respect to polyclonal antibody
production (Levitt et al. 1986, Moulder 1991). However, studies reporting stimulation
o f T-cell proliferation by Chlamydia were controversial. Qvigstad and colleagues
(1983, 1985) observed that T cells from human peripheral blood proliferated in
response to UV-inactivated LGV. However, other investigators (Bard et al. 1984) did
not observe T cell proliferation in response to CT.
Development o f local antibody (secretory IgA) in humans is associated with
protection against chlamydial endocervical reinfection (Johnson 1985). Anti-CT
antibodies in sera from healthy people neutralized the infectivity o f CT (Lin et al.
1992). The neutralization was dependent upon antibody isotype and the cell types
tested (Peterson et al. 1993). Neutralization was enhanced in the presence of
complement (Lin et al 1992). The neutralization was thought to occur by inhibition of
attachment o f EBs to host cells (Byrne et al. 1978, Moulder 1991), since monoclonal
antibodies, which recognize epitopes on MOMP, inhibited attachment (Zhang et al,
1987, Baehr et al. 1988, Stephens et al. 1988). However, antibodies (polyclonal or
monoclonal) to MOMP also inhibited CT inclusion formation without affecting the
attachment of EBs to host cells (Caldwell et al. 1982, Peeling et al. 1984). The latter
indicated that the developmental cycle was halted at some point beyond attachment.
Indeed, it was observed that antibody treatment resulted in fusion o f EBs with
lysosomes (Friis et al. 1972), thereby inhibiting transport o f ATP into RBs (Peeling et
al. 1984).
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The demonstration of chlamydial antigen on infected cell surfaces satisfies one
o f the requirements for cytotoxic T lymphocyte (CTL) activity. The presence of
appropriate class I major histocompatibility (MHC) antigens is the other requirement
for CTL activity. CTL activity was observed in spleen cells from mice immunized
with C. psittaci, indicating that chlamydial antigen could be presented with MHC
class I (Lammert 1982), However, CTL activity was not found in spleens, lymph
nodes or peritoneal exudates from mice immunized with LGV (Pavia et al. 1983).
The role of CTL activity in CT infection remains to be defined.
In animal models, the cell-mediated immune (CMI) response seems to be
essential for resolution of genital CT infections. In female guinea pigs infected by the
agent o f guinea pig inclusion conjunctivitis (GPIC), CMI and humoral responses
cooperated to resolve the infection and provide resistance to reinfection (Rank and
Barron. 1983, Rank ct al 1989). Female athymic nude (nu/nu) mice infected by
mouse pneumonitis agent (MoPn) developed chronic genital infection (Rank et al.
1985). In contrast, B cell-deficient mice were capable o f resolving the infection and
were immune to challenge infection (Ramsey et al. 1988). Furthermore, nu/nu mice
that received MoPn antigen-specific T lymphocyte lines were capable o f resolving the
infection (Ramsey and Rank 1991, Igietsutne ct al. 1991). Thus, in the MoPn mouse
model, T cells eliciting CMI responses were essential for resolution o f the infection
and provision o f immunity against reinfection. Additionally, either MoPn antigenspecific CD4+ or CD8+ T cells were sufficient to protect animals from infection
(Ramsey and Rank 1990). IFN-y production might be a common mechanism o f the
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protection by the two T-cell subpopulations since animals treated with monoclonal
antibody against murine gamma interferon (IFN- 7 ) sustained a significantly prolonged
infection compared to untreated animals (Ramsey and Rank 1991).

Interaction betweenJMacrophages and CT
Human and animal chlamydial infections are associated with
polymorphonuclear and mononuclear (monocyte/macrophage) leukocyte infiltration of
affected tissues (Lammont and Nichols. 1981). The roles of these leukocyte
populations in protecting and resolving the infections in the host may be important
(Branham et al. 1985, Rank ct al. 1985).
In vitro studies indicated that interaction between macrophages and Chlamydia
is complicated. A survey of 10 human lymphoblastoid-myeloid cell lines, for
example, showed that CT biovar LGV multiplied in some lines, entered others but did
not multiply and attached to still other lines but did not enter (Bard et al. 1985).
Human mononuclear phagocytes cultivated in vitro less than 7 days were almost
totally resistant to CT inclusion formation and replication (< 1 0 IFU/ml recovered).
However, LGV survived and replicated (1-9.5 x 105 IFU/ml) in phagocytes cultivated
for more than 7 days. In contrast, CT biovar trachoma was completely inhibited in
such phagocytes (Yong et al. 1987). Similar results were observed by Manor and
Sarov (Manor and Sarov. 1986). Replication o f LGV was completely inhibited in
human peripheral monocytes, but not in monocyte-derived macrophages (MDM^). In
contrast to LGV, C. psiftaci replicated in human monocytes and MDM</>.
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Transmission electron microscopy showed two main types o f phagosomes in the
cytoplasm of CT-infected monocytes at 1 hour pi, one in which the EB was tightly
surrounded by the membrane o f the phagosome and another in which the EB appeared
in an enlarged phagosome. At 24 to 48 hours pi, each phagosome contained a single
EB-like particle or an atypical (damaged) RB, indicating that CT was destroyed in
phagosomes o f human monocytes (Manor and Sarov 1986, Yong et al. 1987). When
human monocytes and MDM$ were added to CT-infected HEp-2 cells, CT recovery
and CT DNA production in HEp-2 cells were reduced ( Manor and Sarov 1988).
Electron microscopy showed that infected HEp-2 cells exposed to MDM<£ contained
small vacuoles with abnormal RBs and very few typical EBs. Compared to
monocytes, MDM<£ exhibited more pronounced inhibition and were less resistant to
chlamydial infection. Direct contact of MDM<£ with the CT-infected cells was
required for effective inhibition. However, addition o f anti-TNF-a antibody to the
system reduced the inhibition of chlamydial DNA production (Manor and Sarov
1988), although the mechanisms involved have not been defined clearly.
The human promyelocyte cell line HL-60 can be induced by phorbol myristate
acetate (PMA) or dimethyl sulfoxide (DMSO) to differentiate along the macrophage
or the granulocyte pathway, respectively. Compared to uninduced HL-60 cells, PMAor DMSO-induced cells have a greater ability to bind, ingest and destroy CT (biovar
LGV), indicating that the ability o f this cell line to interact with and destroy
Chlamydiae correlates with distinct stages o f differentiation (Bard et al. 1987).
Although CT biovar trachoma cannot replicate in human monocytes or
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monocyte-derived macrophages in vitro (Yong et al. 1987), infection o f macrophages
by CT biovar trachoma may lake place in vivo. The evidence for this is that CT EBs
and RBs were found in synovial macrophages of patients with Reiter’s syndrome or
sexually acquired arthritis following urogenital infection by CT serovars D-K
(Ishikawa et al. 1986, Keat ct al. 1987).
Alveolar macrophages isolated from healthy nonsmoking adults exhibited
strong intracellular killing of CT biovar trachoma as well as LGV (Nakajo et al.
1990). But alveolar macrophages obtained from individuals with acquired immune
deficiency syndrome (AIDS) exhibited susceptibility to CT infection (Nakajo et al.
1988).
It has been demonstrated that C. psittad and CT biovar LGV can infect and
replicate in mouse peritoneal macrophages (Wyrick et al. 1978, Kuo 1978, Zhong and
Maza 1988, Huebner and Byrne 1988). No apparent difference between thioglycollateelicited and resident peritoneal macrophages was observed with regard to chlamydial
infection (Wyrick et al. 1978). The intracellular fate o f C. p sittad in peritoneal
macrophages was somehow dependent upon the multiplicity o f infection (MOI).
Survival and multiplication of Chlamydiae were optimal at an MOI o f 1 or less. At a
high MOI (100), macrophage damage occurred immediately, which resulted in
significant reduction of CT survival (Wyrick et al. 1978). EBs pretreated with heat
(56°C for 10-30 minutes) or coated with homologous antibody were rapidly destroyed
in phagolysosomes o f macrophages (Wyrick et al. 1978).
It was observed that peritoneal macrophages from C. /w/V/nci-immunized mice
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were resistant to infection by G psittad, while casein-, protease peptone- or
thioglycollate-elicited macrophages from uninfected mice were equally susceptible to
infection. Macrophages from Mycobacterium tuberculosis BCG- or Listeria
monocytogenes-immumued mice exhibited intermediate susceptibility to infection
(Huebner and Byrne 1988). Resistance of macrophages from the C, psittaciimmunized mice was not due to the ingestion o f fewer organisms, nor were these cells
persistently infected, since Chlamydia could not be recovered from the infected
macrophages, even after an extended incubation period. Although increased
respiratory and oxidative activities were observed in macrophages from the G
/w/t/ocr-immunized mice, treatment o f the macrophages with superoxide dismutase to
abrogate

0

2‘ activity did not affect resistance to chlamydial infection, indicating that

resistance involved an oxygen-independent pathway (Huebner and Byrne 1988).
However, the mechanism(s) responsible for the resistance have not been defined.
In contrast to G p sittad or CT biovar LGV, growth o f CT biovar trachoma in
mouse peritoneal macrophages is not welt documented. Low levels o f CT (104
IFU/ml) were recovered at 48 hours pi from peritoneal macrophages inoculated with
CT serovar B at an MOI of 5 (Kuo 1978). Since the kinetics o f CT recovery were not
determined, the observed infectivity recovered may have reflected residual inoculum.
Therefore, actual replication of CT biovar trachoma in peritoneal macrophages has
not been confirmed.
IFN-y-activated human monocytes and MDM</> have been shown to inhibit
chlamydial infection. Human monocytes and MDM</> utilize both respiratory burst-
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dependent and -independent antimicrobial mechanisms. IFN-y can enhance the effect
o f both pathways (Nathan et al. 1983, Murray et al. 1983, Rothermcl et al. 1986).
Therefore, oxygen-dependent and -independent pathways have been examined as
antichlamydial processes in macrophages. Inhibition o f C. psittad growth by IFN-yactivated human MDM<£ was shown to be an oxygen-independent mechanism
(Rothermel et al. 1986). Depletion of intracellular iron was not the mechanism of the
inhibition, as iron-saturated transferrin did not reverse the intracellular inhibition
(Murray et al 1991). Furthermore, deferoxamine (an iron chelator) did not impair
chlamydia] replication within unstimulated human monocytes (Murray et al 1991).
However, it was reported that IFN-y treatment o f human M DM 0 initially resulted in
a microbiostatic inhibition of intracellular chlamydial development (C. psittad) which
could be reversed by the addition of exogenous tryptophan (Byrne et al. 1989).
Prolonged treatment with IFN - 7 before the addition o f tryptophan resulted in
microbiocidal activity that was irreversible.
Thioglycollate-eliciled mouse peritoneal macrophages activated by IFN - 7 (with
or without LPS) resulted in microbiostatic inhibition of C. p sitta d (Huebner and
Byrne 1988). The inhibitory effect was eliminated shortly after IFN-y was removed
from the culture. Thioglycollate-clicited mouse peritoneal macrophages activated in
vivo with recombinant murine IFN-y significantly restricted CT replication (LGV).
Moreover, mice that received IFN-y-activated macrophages exhibited significant
decreases in CT recovery from their spleens and peritoneal fluids (Zhong and de la
Maza 1988). The mechanism(s) have not been defined. It was observed that the
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restriction of CT replication paralleled expression of Iad on the macrophages (Zhong
and de la Maza 1988). Increase of la expression on macrophages induced by T cellderived IFN-y also was observed in mice infected by other organisms such as
Listeria monocytogenes (Koga et al. 1987). Furthermore, Ia-bearing-macrophage
influx was associated with genetic resistance of mice to infection by Rickettsia
tsutsugamushi (Jerrells 1983). However, the precise role o f la expression in inhibition
o f CT remains unknown.

Effect o f Cvtokines upon Chlamydial Infection

Interferon-^
Interferon - 7 (IFN- 7 ) is produced by Thj lymphocytes (helper T lymphocyte 1)
and has multiple biological functions. These include activation o f macrophages,
participation in T cell differentiation, inhibition o f proliferation of Th 2 lymphocytes
(helper T lymphocyte 2) and antimicrobial activity (Adams and Hamilton 1992, Auger
and Ross 1992, Fitch et al. 1993). The inhibitory effects o f IFN-y upon CT infection
have been examined in vitro as well as in vivo. Stimulation of spleen cells from CT
(serovar Ll)-infected mice by concanavalin A (con A) or heat-killed CT resulted in
the release of high levels o f IFN-y at 5-8 days postinfection (Zhong et al. 1989). IFN7

levels paralleled the clearance o f CT from the mice. Treatment o f CT-infected mice

with monoclonal antibody (MAb) to IFN-y significantly increased recovery o f CT
(Zhong et al. 1989). In vitro. IFN-y activated macrophages (human or mouse) which
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inhibited chlamydial growth as described above and restricted chlamydial infection in
other cells (Rothermel et al. 1983, Maza et al. 1987, Shemer and Sarov 1985, Byrne
et al. 1989). Mouse fibroblasts (L and McCoy cells) and human epithelioid or
epidermoid cell lines (T24, HeLa and HEp-2) treated with IFN-y exhibited inhibition
of inclusion formation. Inhibition of chlamydial recovery also was observed in these
cells. IFN - 7 restricted replication of CT biovar trachoma in primary human
conjunctival epithelial cells (Tahija et al. 1990).
Most investigators have focused upon tryptophan degradation as a mechanism
o f inhibition. IFN-y can induce a variety o f cells to synthesize indoleamine-2, 3deoxygenase (Shemer and Sarov 1987, Byrne et al. 1986, Tahija et al. 1990, Carlin et
al. 1989). This enzyme causes depletion o f tryptophan by degrading it to kynurenine
and N-formylkynurenine. Exogenous tryptophan partially reversed IFN-y-induced
inhibition o f C. psittad in T24 cells or human macrophages (Byrne et al. 1986 and
1989, Carlin et al. 1989). Moreover, tryptophan partially reversed the inhibition o f
CT biovar LGV in HEp-2 cells (Shemer and Sarov 1987). However, exogenous
tryptophan failed to block the action of IFN-y in McCoy cells infected with CT biovar
LGV (de la Maza et al. 1985). This phenomenon also was observed in other murinederived cell lines (Murray et al. 1989, Mayer et al. 1993). Therefore, it is possible
that tryptophan degradation is involved in antichlamydial activity in human cells, but
not in murine cells.

15
Tumor Necrosis Factor a
Tumor necrosis factor a (TNF-a) is produced primarily by macrophages and
has been shown to exert an inhibitory activity in chlamydial infections. In vivo. TNFa was produced in the lungs o f CT-infected mice, where it plays an undefined role in
host defense against infection (Williams et al. 1990). In culture, the effect o f TN F-a
upon chlamydial infection (CT biovar LGV) resembled that o f IFN-y (Shemer-Avni et
al. 1988, 1989). The TN F-a effect was abolished by cycloheximide, indicating that
synthesis o f host protein was required (Shemer-Avni et al 1988). Like IFN-y, TN F-a
induced the degradation o f tryptophan. This is remarkable, since exogenous
tryptophan or anti-IFN-0 antibody partially reversed the inhibition of CT replication
in HEp-2 cells (Shemer-Avni et al. 1989). Inhibition o f CT (biovar LGV) by TN F-a
was accompanied by increased production o f prostaglandin E2 (PGE 2) in HEp-2 cells
(Holtmann et al. 1990). The role o f increased PGE 2 is unclear.

Interleukin-1
Interleukin-1 (IL-1) was induced in human monocytes by live, heat- or UVinactivated EBs (CT biovar LGV) only at a high MOI (Manor et al. 1990, Rothermel
et al. 1989). Recombinant IL -la inhibited CT growth in HEp-2 cells in the absence of
tryptophan degradation. However, PGE2 formation was increased in infected HEp-2
cells treated with IL-1 or T N F-a, but not IFN-y. Tryptophan inhibited PGE2
production and reversed the inhibition o f CT replication induced by exogenous PGE2
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(Shemer-Avni et al. 1990). The precise mechanism involved in this inhibition is not
clear.

NO Production and Inhibition of Microorganisms in Activated Macrophages
Macrophage activation is known to occur through a series o f stages ranging
from a level equivalent to resident tissue macrophages and culminating at an activated
state whereupon macrophages become competent to kill several pathogens and lyse
tumor cells (Adams and Hamilton 1984, 1992). During this activation process,
macrophages produce an array o f biologically active molecules. Nitric oxide (NO) is
one of these products which include superoxide, hydrogen peroxide, T N F-a, IL-1,
IL- 6 , M IP l-a and P G ^ (Stuehr and Marietta 1987, Adams and Halmilton 1992).
NO, a simple and relatively unstable radical, is a potent and pleiotropic
mediator of diverse biological activities (Liew and Cox 1991a, Kolb and KolbBachofen 1992, Moncada et al. 1991). This radical accounts for the activity of an
endothelium-derived relaxing factor, acts as a neurotransmitter and serves as a major
defense molecule against tumor cells, intracellular parasites, fungal and bacterial
pathogens (Liew and Cox 1991, Kolb and Kolb-Bachofen 1992, Moncada et al. 1991,
Stuehr and Nathan 1989).
The first evidence to suggest that macrophages produced nitrite (N 0 2‘) was
that blood levels and urinary excretion o f nitrate (NOy) increased after exposure to
LPS in LPS-sensitive, but not in LPS-resistant mice (Stuehr and Marietta 1985).
These authors also demonstrated that mouse peritoneal macrophages activated by LPS

increased N O / and NO,’ production in vitro. Subsequent work demonstrated that
mouse peritoneal macrophages and macrophage cell lines produced nitrite and nitrate
following stimulation by cytokines or LPS (Ding et al. 1991, Stuehr and Marietta
1985, 1987a, 1987b, Moncada et al. 1991). The production o f NO was dependent
upon the presence o f L-arginine which is converted to cilrulline (Iyengar et al. 1987).
Experiments with , 5N-labeled arginine demonstrated that both N O / and N O / were
derived from the terminal guanidino nitrogen atom(s) o f arginine (Iyengar et al.
1987). It is clear that NO is generated in macrophages from L-arginine catalysis
directed by NO synthase (NOS), NO then is converted to nitrite or nitrate. As NO is
unstable (half life of seconds), nitrite rather than NO production is measured.
Analogues of L-arginine, such as N*-monomethyl-L-arginine (L-NMMA), specifically
inhibited NO synthesis by competitive binding (Figure 2).
There are at least two distinct isoforms o f NO synthase. One is calcium- and
calmodulin-dependent and is constilutively expressed in some cell types of the body,
notably the endothelium and some neurons. The other is not dependent upon calcium
or calmodulin, and is not constilutively expressed. When induced, the latter can
produce large amounts of NO in macrophages and many other cell types (Moncada et
al. 1991). The inducible enzyme is not detectable in macrophage cell lines or freshly
isolated macrophages that have not been activated by LPS or cytokines (Stuehr and
Marietta 1985, 1987a, 1987b). Cellular protein synthesis is required for its expression
(Marietta et al. 1988). There is a lag phase o f approximately
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hours before synthesis

of N O / and N O / is detectable (Stuehr and Marietta 1987a). Recently, cDNA o f the
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Figure 2
The Generation of Nitrite from L-Arginine.
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NOS gene has been cloned from Ihe mouse macrophage cell line RAW264.7 (macNOS, Lowenstein et al. 1992, Lyons et al. 1992, Xie et al. 1992), from bovine aortic
endothelial cells (ecNOS, Sessa et al. 1992) and from rat cerebellum (bNOS, Bredt ct
al. 1991). Comparison of the deduced amino acid sequence o f mac-NOS to that of
bNOS and ecNOS revealed only 50-57% identity (Sessa et al 1992, Lowenstein ct al.
1992).
The capacities of 12 cytokines to induce N O / production in resident or
thioglycollate-elicited mouse peritoneal macrophages were evaluated (Ding ct al.
1988). O f these, only IFN-y induced substantial N O / production. The remainder
(IFN -a, IFN-0, TN F-a, TNF-0, CSF-GM, CSF-M, IL-10, IL-2, IL-3, IL-4 and
TGF-0) were incapable of inducing significant nitrite production. Although neither
T N F -a nor TNF-0 induced nitrite production alone, combination o f either with IFN-y
increased nitrite production six-fold over that in macrophages treated with IFN-y
alone. In combination with LPS, IFN -a or IFN-0 also induced nitrite production,
despite the fact that neither alone was sufficient. IFN-y and LPS acted synergistically
to induce nitrite production. IL-10, a product o f Thz lymphocytes, inhibited
expression o f NOS and nitrite production in IFN-y-activated macrophage cell line
J774A.1 cells (Cunha et al. 1992). The response was dose-dependent. Inhibition
occurred only when the cells were pretreated with IL-10. Addition o f IL-10 after IFN7

activation was not effective (Cunha et al. 1992). IL-4 and TGF-0 also inhibited

nitrite production by IFN- 7 -activatcd macrophages (Liew ct al. 1991b, Ding et al.
1990).
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The effect o f NO production upon intracellular killing o f microorganisms by
mouse peritoneal macrophages has been studied quite extensively. Mouse
macrophages activated by LPS and IFN - 7 exerted a powerful cytostatic effect in vitro
against the fungal pathogen Cryptococcus neoformans (Granger et al. 1986a, 1986b).
This fungistasis was dependent upon the presence of L-arginine, was inhibited by LNMMA and correlated with the synthesis of L-citrulline, nitrite and nitrate (Granger
et al. 1990). Similarly, the cytostatic action of mouse macrophages against
Toxoplasma gondii was prevented by L-NMMA (Adams et al. 1990). Intraperitoneal
administration of killed Corynebacterium parvum in mice led to increased resistance
to infection by Toxoplasma, an effect which was prevented by L-NMMA (Adams et
al. 1990). Intracellular destruction of Leishmania major amastigotes (L. major) was
inhibited by L-NMMA (Green et al. 1990, Liew et al. 1990). Moreover, this parasite
was killed directly by exposure to NO (Liew et al. 1990). Mice infected by L. major
developed larger lesions following in vivo treatment with L-NMMA. The infected
footpads of the L-NMMA-treated mice contained 10* times more parasites than those
o f untreated mice (Liew et al. 1990). NO produced by activated mouse macrophages
also may be involved in the in vitro killing o f Schistosoma mansoni (James and
Claven 1989) and Entamoeba histolytica trophozoites (Lin and Chadee 1992). It is
notable that the effect o f NO in inhibition of CT by mouse macrophages, to our
knowledge, has not yet been reported.
Most studies have indicated that human monocytes and MDM<£ stimulated with
IFN - 7 in vitro or in vivo did not produce enhanced levels of nitrite (Murray and

Tertelbaum 1992, James et al. 1990, Cameron et al. 1990). Neither L-NMMA nor
arginase inhibited intracellular antimicrobial activity (Murray and Tertelbaum 1992).
James and his coworkers (James et al. 1990) reported that human MDM<£ activated in
vitro by IFN - 7 killed Schistosoma mansoni, but did not produce nitrite. Cameron and
his coworkers (Cameron et al 1990) showed that human alveolar and peritoneal
macrophages inhibited replication o f intracellular Cryptococcus neoformans without
producing nitrite or nitrate. The authors observed that L-NMMA did not affect
anticryptococcal activity. In addition, the killing of Mycobacterium avium,
Toxoplasma gondii, Chlamydia psittaci or Leishmania donovarti by human monocytes
was not diminished by L-NMMA or arginase (Murray and Teitelbaum 1992). At the
same time, it remains possible that the generation o f NO may play some antimicrobial
role in vivo, which for unclear reasons cannot be readily demonstrated in vitro using
human cells. Recent studies in cancer patients treated with IL-2, for example, have
indicated the presence o f cytokine-inducible nitrite production in serum and urine
(Billiar et al. 1991, Murray et al. 1989). Furthermore, 14-day old human monocytederived macrophages have been reported to generate nitrite after prolonged (7-day)
intracellular infection by the slowly growing pathogen Mycobacterium avium (Denis
1991). Eight days of concurrent treatment with TN F-a or CSF-GM increased nitrite
production and induced killing of M, avium, L-NMMA or arginase reversed the
effect. It is possible that human macrophages may be stimulated to produce NO only
in response to a particular cytokine or pathogen.
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Summary
Chlamydial genital infection is prevalent throughout the would. Interaction
between macrophages and CT is important in host defense against the infection. C.
psittaci and CT biovar LGV have been demonstrated to grow in inactivated
macrophages, but replication o f CT biovar trachoma in macrophages is not well
documented. Cytokines such as IFN - 7 and TN F-a have been shown to inhibit CT
infection. However, the mechanisms involved have not been defined. Although NO
has been identified as a major defense molecule against a variety o f microorganisms,
the effect of NO in inhibition of CT by activated mouse macrophages is unknown.
Therefore, this study was initiated to demonstrate replication of CT biovar trachoma
(scrovar D) in mouse peritoneal macrophages and macrophage cell lines.
Subsequently, correlation between NO production and CT inhibition in these cells was
analyzed. We observed a strong correlation between nitrite production and inhibition
o f CT replication in macrophage cell lines (RAW264.7 and J774A .I). L-NMMA
partially reversed the inhibition. Our data suggest that NO is one o f the mechanisms
involved in inhibition o f CT replication in IFN-y-activated macrophages.

CHAPTER 2
Materials and Methods

Materials

Buffers and Solutions
Dulbecco’s phosphate buffered saline (DPBS) was purchased from Sigma
Chemical Co. DPBS consisted of 0.9 mM calcium chloride, 2.68 mM potassium
chloride, 1.47 mM potassium phosphate monobasic, 0.49 mM magnesium chloride,
0.137 M sodium chloride and 8,06 mM sodium phosphate dibasic.
Trypsin-EDTA containing 0.25% trypsin and 1 mM EDTA was purchased
from Gibco. Fetal bovine serum (FBS) was purchased from Sigma Chemical Co. FBS
was inactivated at 56°C for 30 minutes before use.
IFA (Immunofluorescence Assay) buffer was phosphate buffered saline
prepared according to the manufacturer’s instructions.
Glucose, Tris-HCl, EDTA (ethylenediaminetetraacetic acid), NaOH, SDS
(lauryl sulfate sodium salt), potassium acetate, NaCl, sodium citrate, NaH 2P 0 4,
Na2H P 04, crystal violet, RNase A, ethidium bromide, 37% formaldehyde, MOPS (3N-morpholinopropanesulfonic acid), DEPC (diethylpyrocarbonate), bromphenol blue,
xylene cyanol, sulfanilamide and naphthylethylenediamine dihydrochloride (NEDD)
were purchased from Sigma Chemical Co. Phenol, chloroform, isoamylalcohol,
isopropanol, ethanol, methanol, HC1, phosphoric acid and ion-exchange resin were
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purchased from Fisher Scientific.
Distilled water used to prepare buffers and solutions for RNA isolation and
hybridization was treated with DEPC, and then autoclaved for 30 minutes at 1210C.
Formamide was deionized by mixing 50 ml o f formamidc with 5 g o f ionexchange resin (Bio-Rad AG501-X8), stirring 30 minutes at room temperature and
filtering through Whatman filter paper. Deionized formamide was aliquoted and
stored at -20°C.
GTE buffer was 50 mM glucose, 25 mM Tris-HCl (pH 8.0) and 10 mM
EDTA. Alkaline lysis buffer was 0.2 N NaOH with I % SDS. Potassium acetate
solution was 5 M, pH 4.8. TE buffer was 10 mM Tris-HCl (pH 8.0) and 1 mM
EDTA. TBE was prepared as a lOx stock solution which contained 0.89 M Tris base
and 0.89 M boric acid, 20 mM EDTA. 10X MOPS buffer was 0.2 M MOPS, 80 mM
sodium acetate (pH 7.0), 10 mM EDTA (pH 8.0). lOx loading buffer (pH 8.0) was 1
mM EDTA, 0.25% bromphenol blue, 0.25% xylene cyanol and 50% glycerol.
Ethidium bromide (EB) solution was prepared as a 10,000x stock (5 mg/ml). 20 x
SSC was 3 M NaCI and 0.3 M sodium citrate adjusted pH to 7.0 with 1 M HCI. 2 x
SSPE was 0.36 M NaCI, 20 mM NaHjPO, (pH 7.4) and 20 mM EDTA.
RNase A was dissolved in TE buffer by boiling for 10 minutes to make a
concentration o f 10 mg/ml. Aliquots were stored at -2CfC.
Denaturing solution 1 for Dot Blot was 4 ml 20x SSC mixed with 1 ml 37%
formaldehyde. Denaturing solution 2 for Northern Blot was 50 pi lOx MOPS mixed
with 89.4 pi 37% formaldehyde, 250 pi formamide and 110.6 pi DEPC-treated
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distilled water.

Formaldehyde denaturing agarose gel was 1 % agarose in 1 X

MOPS buffer with 2.2 M formaldehyde and 0.5 ng/m \ EB.
Prehybridization solution was 0.5 M phosphate buffer (Na2H P 0 4/NaH 2P 0 4),
pH 7.5, with 7% SDS and 100 jtg/ml denatured herring sperm DNA. Washing buffer
1 was 0.1 M phosphate buffer with 1% SDS. Washing buffer 2 was 0.01 M
phosphate buffer with 0.1% SDS.
A commercially prepared lOx buffer coming with restriction endonuclease Not
I (Promega) was 60 mM Tris-HCl, pH 7.9, 1.5 M NaCI, 60 mM MgClj and 10 mM
DTT.
Griess reagent for nitrite assay was 1% sulfanilamide, 0.1% NEDD and 2.5%
phosphoric acid.
Crystal violet solution (lOx) for TN F-a assay was 2% crystal violet in 21%
ethanol.
Thioglycollate broth was purchased from Difco. 3% (w/v) of thioglycollate
was prepared, autoclaved to sterilize and stored in the dark at room temperature.

Media
RPMI-1640 medium, Dulbecco’s Modified Eagle’s Medium (DMEM) powder,
lOx MEM (Eagle’s minimum essential medium), glutamine, HEPES (N-2hydroxyethylpiperazine-N-2-ethanesulfonic acid), sodium bicarbonate, sodium
pyruvate, cycloheximide (CH), gentamicin sulfate and ampicillin were purchased from
Sigma Chemical Co. Ham's Nutrient Mixture F12 (Ham’s F12) powder was
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purchased from Gibco. Tryptone, yeast extract, Bacto-agar were purchased from
Difco. IFTG (Isopropyl-1-thio-fJ-D-galactoside) and Xgal (5-Bromo-4-chloro-3indolyl-0-D-gaIactosidc) were purchased from Promega.
McCoy cell growth medium was IX MBM. For 500 ml growth medium, 50
ml 10X MEM were diluted with 450 ml sterile distilled water, then supplemented
with 10 ml 27% glucose, 10 ml 1 M HEPES (pH 7.3), 50 ml FBS (unless otherwise
indicated in separate experiments), 5 ml 7.5% sodium bicarbonate, 0.2 ml 50 mg/ml
gentamicin sulfate and 5 ml 200 mM glutamine. Fresh glutamine was added after four
days o f storage, CH medium was McCoy cell growth medium complemented with CH
(1 pg/ml).

Macrophage growth medium was RPMI-1640 with 5% FBS (unless

otherwise indicated in separate experiments), 10 mM HEPES (pH 7.3), 2 mM
glutamine, 1 mM sodium pyruvate and 50 pg/ml gentamicin sulfate.
OVCAR3 growth medium was RPMI-1640 medium with 10% FBS, 20 pg/ml
gentamicin sulfate, 20 mM HEPES, 2 mM glutamine and 10 pg/ml insulin.
KLE growth medium was a 1:1 mixture o f lx DMEM and lx Ham’s F12 with
10% FBS, 20 pg/ml gentamicin sulfate and 20 mM HEPES adjusted to pH 7.4 with
sodium bicarbonate.
Medium for E. coli growth was LB medium containing 10 g tryptone, 5 g
yeast extract, 5 g sodium chloride and 1 ml o f 1 N NaOH in 1000 ml o f medium.
Selective antibiotic plates were prepared by melting 1.5 g Bacto-agar (Difco) in 100
ml LB medium supplemented with ampicillin (50 /xg/ml), IPTG (0,1 mM), Xgal (20
pg/ml). The selective antibiotic plates were prepared one day before use.
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Reagents
Recombinant mouse tumor necrosis factor (iTN F-a, 10 pg/ml) was purchased
from Genzyme, The specific activity o f iT N F-a was 4X107 units/mg. Polyclonal
rabbit anti-mouse TN F-a antibody (anli-TNF-a Ab, primarily IgG and IgM) was
purchased from Genzyme. One /d of anti-TNF-a Ab neutralized approximately 1000
units o f mouse TN F-a bioactivity in the standard L929 cell cytotoxicity assay.
Recombinant mouse interferon-y (IFN-y, 1 x 10J units/ml) was purchased from Gibco
BRL Life Technologies. The specific activity of IFN-y was approximately 1 x 107
units/mg. Lipopolysaccharide (LPS, Escherichia coli, 026:B6), N°-monomclhyl-Larginine acetate (L-NMMA) and L-tryptophan were purchased from Sigma Chemical
Co.
Ultraspec™ RNA (a total RNA isolation reagent) was purchased from Biotecx
Laboratories. RNA markers, DNA markers (lambda DNA/Hind III), herring sperm
DNA, restriction endonuclease Not I and Prime-a-Gene labeling system were
purchased from Promega. Deoxycytidine 5’-[a-HP] triphosphate (3IP-dCTP) was
purchased from Amersham.

Plasmid and cDNA
The plasmid CL-BS-mac-NOS was generously provided by C.J. Lowenstein,
Johns Hopkins University, Baltimore, MD. The recombinant plasmid was made from
the Bluescript vector sold by Stratagene, with the 4100 bp (base pairs) fragment from
the macrophage nitric oxide synthase cDNA (mac-NOS) inserted into the unique Not I
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site. Chicken 0-actin cDNA was originally isolated by Cleveland et al. (1980) and
generously provided by R. D. Stout, East Tennessee State University (ETSU),
Johnson City, TN.

Stains
An anti-MOMP (major outer membrane protein) monoclonal antibody
conjugated with F1TC was purchased from Syva (Microtrak CT culture Confirmation
System). Jones’ iodine was prepared by mixing 50 ml 95% ethanol, 5 g iodine, 5 g
potassium iodide and 50 ml distilled water in order and filtering through two
Whatman tt\ filters.

Ceils
McCoy cells were a generous gift from Dr. J. Schachter, San Francisco, CA.
L929 cells were generously given by Dr. R.D. Stout, ETSU, Johnson City, TN.
Mouse macrophage cell lines: J774A.1 and RAW264.7 cells, human epithelial cell
lines: OVCAR-3 and KLE, and JM109 (a strain o f E. Coli) cells were purchased
from American Type Culture Collection (ATCC).

ChlamvdiaJrachomalis
The strain of CT used in this study was a serovar D. The organism was
isolated in our clinical laboratory from a conjunctional swab obtained from the left
eye o f a two-
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week old girl suffering from a perinatal infection. Tlie organism has been passed an
indeterminate number of times in McCoy cells since isolated.

Animals
Inbred female BALB/c mice were purchased from Charles River Laboratories.
The mice were housed in isolation in the Division of Laboratory Animal Resources
(DLAR), James H. Quillen College of Medicine.

Miscellaneous
XAR-5 X-ray Him was purchased from Sigma Chemical Co. SeaKem LE
agarose was purchased from FMC Bioproducts. Nytran plus nylon membranes were
purchased from Schleicher & Schuell. Whatman papers (3M) were purchased from
Fisher Scientific. DEAE-cellulose membrane was purchased from Schleicher and
Schuell, and treated as follows before use: soaking the membrane for 5 minutes in 10
mM EDTA, pH 8.0, then soaking the membrane in 10 mM EDTA with 0.5 N NaOH
for 5 minutes, finally washing the membrane six times in sterile water.
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Methods

Cell Cultures
McCoy, OVCAR-3 and KLE cells were grown and maintained in McCoy
growth medium, OVCAR-3 growth medium and KLE growth medium, respectively.
The cultures were incubated at 37°C in a humidified atmosphere with 5% C 0 2.
Confluent monolayers were trypsinized, washed and counted. Viability o f cells were
determined by trypan blue exclusion (Mishcll and Shiigi 1980).
RAW264.7, J774A.1 and L929 cells were grown and maintained in
macrophage growth medium at 37°C in a humidified atmosphere with 5% C 0 2.
Confluent monolayers were scraped gently using a sterile rubber policeman. Number
and viability o f cells were determined as described as above.

Preparation of CT Seed Pool
Confluent monolayers o f McCoy cell were trypsinized. 5 x 10’ cells in 1 ml of
McCoy growth medium were added to each shell vial containing a 12 mm coverslip.
Each vial was closed with a sterile #0 neoprene stopper and incubated at 37°C
overnight. After aspiration of supernatant, the cells were inoculated with CT (0.1 ml
inoculum/vial) at a multiplicity o f infection (MOI) o f 0.5-1 and centrifuged at 900 X
g for 45 minutes at room temperature. 1 ml o f CH medium was added to each vial
and the vials incubated at 37°C for 48 hours. After incubation, the supernatant was
aspirated and 0.5 ml of fresh macrophage growth medium with sterile 4 mm glass
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beads were added to each vial. The vials were vortexed 10 seconds for three times.
The crude lysates from 70 vials were pooled, dispensed into 0.5 or 1.0 ml aliquots
and stored at -800C. The lysate served as CT seed pool. Titration of the CT Seed Pool
was performed on McCoy cells (see CT recovery).

Preparation of Peritoneal Macrophages
Thioglycollate-elicitcd peritoneal macrophages (thio-macrophages) were
generated as described Mishell and Shiigi, 1980. Briefly, mice were injected
intraperitoneally with 3% thioglycollate. At day five post-injection, mice were
sacrificed by cervical dislocation. Peritoneal exudative cells were harvested by
washing peritoneal cavity with DPBS containing 2% FBS, and resuspended to 5 X 10s
cells/ml in macrophage growth medium. The cell suspension (1 ml) was added to each
shell vial containing a 12 mm coverslip. The vials incubated at 37°C overnight and
nonadherent cells were removed by washing with DPBS.

CT Recovery on McCov Cells
The procedure used for CT recovery was described by Smith, 1979. Briefly, 5
x 10* freshly trypsinized McCoy cells in 1 ml of McCoy growth medium were
dispensed into each shell vial containing a 12 mm coverslip. The vials incubated at
37°C overnight, at which time medium was aspirated from the monolayers and 100 /xl
o f CT inoculum were added to each vial. After centrifugation at 900 X g for 45
minutes at room temperature, the inoculum was removed and 1 ml CH medium was
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added to each vial. After incubation at 37°C for 48 hours, the monolayers on
covcrslips were fixed with methanol for 30 minutes and stained with Jones’ iodine for
10 minutes. The coverslips were inverted and mounted on microscope slides with
glycerohJones’ iodine (1:1). The number o f inclusions on each coverslip was counted
under a light microscope. The number o f IFU/ml (inclusion forming units per ml)
was determined by a formula: No. IFU/ml = No. Inclusions/coverslip x reciprocal
dilution x 10. Quantitation of CT recovery reflected extension o f CT replication,

FITC-coniugated Anti-MOMP Slain
For determination of initial inclusions, infected monolayers were stained with
FITC-conjugated anti-MOMP according to the manufacturer's instructions. Briefly,
cells on coverslips were fixed and incubated with FITC-conjugated anti-MOMP at
37°C for 30 minutes in a moist chamber, rinsed with IFA buffer and mounted on
slides, Inclusions were counted under a Reichert fluorescent microscope.
To reslain coverslips previously stained with iodine, the covcrslips were placed
in 2 ml IFA buffer for at least one hour to remove all traces o f the iodine. Then the
coverslips were stained with FITC-conjugated anti-MOMP as described above. Yield
of CT was determined as follows: No. IFU m l 1 / total initial inclusions (i.e., the
number o f IFU recovered per inclusion).

Initial Inclusions and Kinetics of CT Recovery
In order to demonstrate CT infection and replication in cells, initial inclusions
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were measured and kinetics o f CT recovery performed. Peritoneal macrophages,
macrophage cell lines (J774A.1 and RAW264.7) or McCoy cells (control) were
planted in shell vials (5 X 10' cells/ml/vial) and incubated at 37°C overnight.
Following aspiration of the medium, 0.1 ml o f CT Seed Pool (1:3 dilution) were
added to each vial (MOI: 1-2). The vials incubated at 37°C for 90 minutes. After
adsorption, the inoculum was aspirated and the monolayers were washed gently three
times with DPBS. Macrophage growth medium (1 ml) was added to each vial. The
vials incubated at 37"C for 3 or

6

days. Addition of inoculum to shell vials without

cells served to define background. At different time points pi, recovery o f CT from
supernatant or lysate o f infected cultures was measured on McCoy cells as described
previously. Replicate monolayers were fixed and stained with iodine or FITCconjugated anti-MOMP to quantitate inclusion formation.

Nitrite Assay
The method used to measure nitrite production was based upon that described
by Stuehr and Marietta (1987). Briefly, 50 pi of supernatant from each culture was
mixed with an equal volume of Griess reagent in a 96-well plate. The plate was
incubated at room temperature for 10 minutes. The OD J70 was determined by an
automated plate reader (VMAX, Molecular Devices Corporation, Menlo Park, CA).
Sodium nitrite served as a standard. Nitrite concentration was quantitated by using the
standard curve generated in each assay.
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TN F-a Assay
The T N F-a assay was described by Ruff et al. (1981) and Hansen et al.
(1989). Briefly, 100 ft\ o f supernatant from each culture were mixed with 100 nl o f
the L929 cell suspension containing 4 pg/ml of actinomycin D in a 96-well plate. The
plate was incubated overnight at 37°C in a humidified atmosphere with 5% C 0 2.
Medium was discarded and the monolayers were stained with a crystal violet solution
(0.2%) for 10 minutes. After the plate was washed 6-7 times with tap water, 100 jtl
of 1% SDS was added to each well and the plate was shaken for 1 minute. The ODJ3*
was measured as described above. Mouse iTN F-a served as a standard. Concentration
o f TN F-a was determined by using the standard curve generated at the same time.

Treatment of Uninfected Cells with LPS and/or IFN - 7
RAW264.7, J774A.1 and McCoy cells were planted as described previously.
After incubation at 37°C overnight, the medium was aspirated and 1 pg LPS, 100 U
IFN - 7 or both was added to each vial in 1 ml o f macrophage growth medium. The
vials were incubated at 37°C for

6

days. During incubation, half of medium (0.5 ml)

was replaced by fresh growth medium at day 3 post-trcatment (pt). In a second set of
vials, medium was completely replaced by fresh growth medium every 24 hours,
TN F-a and nitrite production were measured as described previously in supernatants
at different time points.

LPS Dose Curve
RAW264.7, J774A.1 and McCoy cells were planted as described as
previously. At the time o f treatment, 1 ml o f macrophage growth medium containing
different concentrations of LPS (from 0.001 to 10 pg/ml) was added to the cells. At
48 hours pt, nitrite production in supernatant was measured as described previously.
LPS at a concentration 100 ng/ml was optimal for stimulation o f nitrite production.
Therefore, 100 ng/ml o f LPS was used in subsequent experiments.

Treatment of CT-lnfected Cells with LPS and/or IFN-y
RAW264.7, J774A.1, McCoy, KLE and OVCAR-3 cells were planted and
inoculated with CT as described in Kinetics of CT Recovery. Al 24 hours pi, the
infected cells were treated with LPS (100 ng) and/or IFN-y (100 U) as described. At
different time points pt, nitrite and TN F-a production was measured in the
supernatants. CT recovery from supernatants or lysates was quantitated on McCoy
cell cultures as described previously.

Blocking o f Nitrite Production bv L-NMMA
Dose curve o f L-NMMA. RAW264.7 cells were planted and treated with
rIFN-y and LPS as described previously. At the time of treatment, L-NMMA (from
0.001 mM to 10 mM) was added to each vial. At 24, 48 and 72 hours pt, nitrite
production was measured as described.
Specific inhibition of nitrite production by L-NMMA. RAW264.7, J774A.1
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and McCoy cells were planted and treated with IFN-y, LPS or both as described. At
the time of treatment, I mM o f L-NMMA was added to each vial. At 24, 48, 72
hours pi, nitrite and TN F-a production were measured in the supernatants as
described.
Abrogation o f CT inhibition by L-NMMA. RAW264.7, J774A.1 and McCoy
cells were planted and inoculated with CT as described previously. At 24 hours pi,
the CT-infccted cells were treated with LPS and/or IFN-y in presence o f different
concentrations o f L-NMMA (from 0.1 to 5 or 10 mM) as described above. At 48
hours pt, nitrite and TNF-a production were measured as described. Concomitantly,
CT recovery from lysate was quantitated in McCoy cell cultures as described.

Treatment of CT-infected Cells with Sodium Nitrite
RAW264.7 cells were planted and inoculated with CT as described previously.
At 24 hours pi, medium was aspirated and fresh macrophage growth medium
containing different concentrations of sodium nitrite (from 50 to 200 nmol/ml) was
added to the infected cells. At 48 hours pt, TN F-a production and nitrite
concentration in supernatant were measured. CT recovery from lysate o f the infected
cultures was quatitatcd as described previously.

Role o f Trvntophan Degradation in Inhibition o f CT Replication
RAW264.7 cells were planted, inoculated with CT and treated with IFN-y and
LPS as described previously. At the time o f treatment, different amounts of
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tryptophan (from 40 to 1000 /ig/ml) were added to each vial. In a separate
experiment, the amount of tryptophan and 1 mM o f L-NMMA were added to each
vial. At 48 hours pt, nitrite and TN F-a production were measured. Concomitantly,
CT recovery was quantitated in McCoy cell cultures as described.

Isolation o f Total RNA
Total RNA was isolated from cell cultures using a commercial total RNA
isolation reagent according to the manufacturer's instructions. Briefly, monolayers
were lysed directly in shell vials by adding Ultraspcc™RNA and pipeting the cell
lysate several times. The cell lysate was transferred immediately to a microcentrifuge
tube which was immersed in ice. Five minutes were allowed to permit the complete
dissociation o f nucleoprotein complexes. Chloroform (0.2 ml per 1 ml of
UItraspec™RNA) was added and the tubes were shaken vigorously for 15 seconds.
The homogenate was centrifuged at 12,000 X g for 15 minutes at 4°C . The top
aqueous phase was carefully transferred to a fresh tube. An equal volume of
isopropanol was added and the samples were cooled at 4°C for 10 minites. Total RNA
was pelleted by centrifugation at 12,000 X g for 10 minutes at 4°C, The pellet was
washed twice with 75% ethanol by vortexing and subsequent centrifugation at 7,500
X g for 5 minutes at 4°C. The pellet was briefly dried, then dissolved in 50 fil o f
DEPC-trealed distilled water. This method generally yielded 10 pg o f total RNA
from 1 x 10* cells. The OD 2H/O D 280 ratio was approximately 1.5.
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Preparation o f NOS cDNA Probe

Transformation of JM109 cells with Plasmid DNA
JM109 cells were transformed with CL-BS-mac-NOS plasmid DNA using a
calcium chloride procedure (Ausubel et al, 1992). Briefly, JM109 cells were grown in
50 ml o f LB medium to

0 0 6 0 0 = 0 .4 3 7 .

The bacterial cells were centrifuged at 800 X

g for 10 minutes. The cell pellet was resuspended gently in 25 ml of an ice-cold,
sterile solution o f 50 mM CaCI2 and placed in an ice bath for 15 minutes. The cells
were centrifuged again, rcsuspendcd in 2 ml of an ice-cold 50 mM CaClj and
incubated at 4°C overnight. Two hundred pi of the cell suspension were mixed with
50 ng of the plasmid DNA (in 5 pi TE buffer, pH 8.0) in a microcentrifuge tube. The
cells were mixed with TE buffer alone as a control. The mixtures were incubated on
ice for 30 minutes and then placed in a heated water bath (42°C) for 2 minutes.
Following the heat shock, LB medium (0.5 ml) was added to each tube and the tubes
were incubated at 37°C for 1 hour. Then selective antibiotic plates were inoculated
with the transformed cell suspension (100 pi). After incubation o f the plates at 37°C
for 16 hours, colorless colonies appeared only in the plates inoculated with the
plasmid-transformed cells. No colonies were observed in the plates inoculated with
the control cells.

Isolation o f Plasmid DNA
One colony isolated as described above was picked to inoculate 30 ml LB
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medium containing 50 pg/ml ampicillin. After overnight shaking at 37°C , the plasmid
DNA was isolated by a method for minipreps described by Davis et al. (1986).
Briefly, the cells were resuspended in 700 pi o f GTE buffer containing lysozyme (2
mg/ml), incubated at room temperature for 5 minutes and mixed with alkaline lysis
buffer (1.7 ml) by inversion of the tube. After cooling on ice for 5 minutes, the cell
lysate was mixed with 1,26 ml o f ice cold potassium acetate solution (5 M, pH 4.8).
After centrifugation at 6,000 X g at 4°C for 10 minutes, the supernatant was collected
and treated with RNase A (50 pg/ml) at 37°C for 1 hour. The treated supernatant was
subsequently extracted twice with an equal volume o f a phenol:chloroform:
isoamylalcohol (25:24:1) mixture. The plasmid DNA was precipitated in ice cold
isopropanol and centrifuged at 7,500 X g for 15 minutes. The plasmid DNA pellet
was washed with 75% ethanol, dehydrated with 100% ethanol, briefly dried and
dissolved in 300 pi o f TE buffer. The ODi^/OD^,, ratio o f the sample was 1.93.

Isolation o f Insert fNOS cDNAI from the Plasmid DNA
Isolation o f the insert was performed by modification o f a procedure described
by Sambrook et al. (1989a). Briefly, 10 pg o f the plasmid DNA was digested by Not
I (1 U/pl) in 100 pi of the reaction solution at 37°C overnight. The digisted plasmid
DNA was run on a 0.8% agarose gel containing 0.5 pg/ml ethidium bromide at 18 V
(1.3 V/cm) overnight. Then a piece of the treated DEAE-celluIose membrane (see
materials) was inserted in front of the leading edge of the band with 4100 bp.
Electrophoresis was resumed at 80 V for 25 minutes to allow migration o f all DNA of
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the band onto the membrane. The membrane was rinsed with a low salt washing
buffer (50 mM T risC l, pH 8.0, 0.15 M NaCl, 10 mM EDTA, pH 8.0). The
fragment was eluted from the membrane by washing with a high salt elution buffer
(50 mM Tris Cl, pH 8.0, 1 M NaCl, 10 mM EDTA pH 8.0) at 65°C for 60 minutes.
The eluate was subsequently extracted once with a mixture o f
phenol:chloroform:isoamy!alcohol as described previously. Then, the fragment was
precipitated with isopropanol and dissolved in TE buffer. Figure 3 shows the band of
isolated NOS-cDNA and the recombinant plasmid DNA before and after the
digestion.

Radiolabelling of NOS cDNA
The NOS cDNA isolated as above was labeled with 3IP-dCTP by random
primer labeling using a Prime-a-Gcne Labeling System Kit according to
manufacturer's instructions. Briefly, 40 fd sterile water, 20 /d 5 X labeling buffer, 4
/d mixture o f the dATP, dTTP and dGTP, 20 /d denatured NOS cDNA (50-100 /ig),
4 /d nuclease-free BSA, 100 nC\ [a-HP] dCTP, 10 units o f Klenow enzyme were
mixed in a microcentrifuge tube on ice. The total reaction volume was 100 fd. The
mixture was incubated at room temperature for 60 minutes. The reaction was
terminated by heating at lOO't for

2

minutes and subsequently chilling in an ice bath.

The labeled probe was stored at -20°C. Probes with specific activities o f more than
I 0 9 cpm//xg were routinely generated by this method.
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Figure 3
NOS cDNA isolated from CL-BS-mac-NOS plasmid. Lane a, lambda DNA/Hind
HI markers; Lane b, CL-BS-mac-NOS plasmid DNA; Lane c, Not I-digestcd CL-BSmac-NOS plasmid DNA; Lane d, isolated NOS cDNA; Lanes e-j, lambda DNA 15.6,
31.2, 62.5, 125, 250 and 500ng, respectively. Ethidium bromide-stained agarose gel.
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Dot Blot Hybridization
The dot blot method was a modification o f that described by Sambrook et al.
(1989b). Briefly, RNA samples (1 pg o f sample RNA in 100 p! o f denaturing solution
1) were denatured by heating at 65DC for IS minutes and subsequently chilling on ice.
For titration o f NOS mRNA, serial dilution of the RNA sample (4 pg -

8

ng) from

LPS- and IFN-y-treated RAW264.7 cells was performed. To confirm the
hybridization with RNA, 4 pg o f the RNA sample from LPS- and IFN - 7 treated
RAW264.7 cells were treated with RNase A (10 pg/pg RNA) before denaturation.
The denatured RNA samples were blotted onto Nytran plus nylon membranes using a
"dot blot" apparatus (Gibco BRL Life Technologies). The membranes were UVcrosslinked and baked at 80nC for 1 hour. Then, the membranes were prehybridized
in prehybridization solution at
denatured

32P-labeled

6 8 °C

for 3 hours and subsequently hybridized with

NOS-cDNA probe in the same solution at

6 8 °C

for 16 hours.

After hybridization, the membranes were washed twice in washing buffer 1 for 15
minutes at room temperature and twice in washing buffer 2 for 15 minutes at 65°C.
The membranes were then exposed to X-ray films in cassettes with intensifying
screens (Fisher Scientific) at -80t'C for 1-2 days. The films were developed and fixed
using Kodak GBX developer and fixer solutions. The density o f the dots was
measured by Bio-Image Analysis System (Millipore Corporation Imaging Systems,
Ann Arbor, Ml). Hybridization with a j3-actin cDNA probe served as a control. Blots
were stripped o f probe by washing with 2 x SSPE containing 50% formamide at

6 8 °C

for 2 hours, then with 0.7 x SSPE containing 50% formamide at 80nC for 2 hours.

Northern Blot Hybridization
The Northern blot method was based upon that described by Sambrook et al.
(1989b). Briefly, RNA samples (10 pg of RNA in 20 pi denaturing solution 2) were
denatured by heating at 65°C for 15 minutes. The denatured RNA samples were
chilled on ice. Two pi o f lOx loading buffer were added to each o f the denatured
RNA samples. Five pg o f a RNA markers were denatured as above. Also, two pg of
the loading buffer were added to the denatured markers. Then, the RNA samples and
the markers were run on a

1%

formaldehyde denatured agarose gel

(2 0

x

20

cm2) in

1

x MOPS buffer at 90 V for 4 hours. The gels were photographed over a UVtransilluminator (FisherBiotech™, Fisher Scientific). RNA was transferred from the
agarose gel onto a Nytran plus nylon membrane using a capillary transfer method
(Sambrook et al. 1989b). The membranes were UV-crosslinked and baked at 80°C for
1 hour. The membranes were prehybridized and hybridized as described above.

Kinetics of NOS mRNA Expression
RAW264.7 cells were planted, inoculated with CT and treated with LPS
and/or IFN-y as described previously. At 6 , 24 and 48 hours pt, total RNA was
isolated as described previously. NOS mRNA expression was determined by Northern
blot hybridization as described.

44
Effect o f Anti-TNF-a Ab upon NO Production and
Inhibition of CT Replication in RAW264.7 Cells
RAW264.7 cells were planted and inoculated with CT as described previously.
At 24 hours pi, the cells were divided into 16 groups as shown in Table 1.
Table 1
EXPERIMENTAL PROTOCOL FOR INVESTIGATING INHIBITION OF CT
REPLICATION IN RAW264.7 CELLS

Treatments

None Anti-TNF-a

L-NMMA

Ab

Anti-TNF-a
Ab & L-NMMA

None

1

2

3

4

IFN - 7

5

6

7

8

LPS

9

10

11

12

IFN - 7 & LPS

13

14

15

16

Group 1 served as an untreated control. Group 2 was treated with anti-TNF-a
Ab. Group 3 was treated with L-NMMA. Group 4 was treated with the Ab and LNMMA. Group 5 was treated with IFN- 7 . Group

6

was treated with IFN - 7 and the

Ab. Group 7 was treated with IFN - 7 and L-NMMA. Group
7

8

was treated with IFN-

, the Ab and L-NMMA. Group 9 was treated with LPS. Group 10 was treated with

LPS and the Ab. Group 11 was treated with LPS and L-NMMA. Group 12 was
treated with LPS, the Ab and L-NMMA. Group 13 was treated with IFN - 7 and LPS.
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Group 14 was treated with IFN- 7 , LPS and the Ab. Group 15 was treated with IFN7

, LPS and L-NMMA. Group 16 was treated with IFN-7 , LPS, the Ab and L-

NMMA.
At

6

hours pt, total RNA was isolated and NOS-mRNA was measured by dot

blot and Northern blot hybridization as described previously. At 48 hours pt, nitrite
and TN F-a production in supernatant were measured as described previously.
Concomitantly, recovery o f CT from lysates o f the infected cell cultures was
performed as described. For these experiments, 100 ng/ml LPS, 100 units/ml IFN- 7 ,
1 mM L-NMMA and

8

/d/ml anti-TNF-a Ab were used.

Effect of Nitrite Production Upon CT Replication in
LPS- and/or IFN-7 -treated Peritoneal Macrophages
Peritoneal macrophages were generated and inoculated with CT as described
previously. At 24 hours pi, the infected macrophages were divided into 16 groups and
each group was treated as described above. At 48 hours pt, nitrite and TN F-a
production in supernatant were measured. At the same time, CT recovery from
lysates o f the infected cultures also was performed as described.

Treatment of Cells with rTNF-q
Post-inoculation treatment. McCoy cells were plated and incubated as
described. At the time o f inoculation, the medium was aspirated, then 0.1 ml of CT
inoculum (MOI =’0.006) was added to each vial. The vials were centrifuged at 900 X
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g at room temperature for 45 minutes. After centrifugation, the inoculum was
aspirated and 250 ng of rTN F-a in 1 ml o f McCoy growth medium (5% FBS) was
added to each vial. The vials were incubated at 37°C for 2 days.
Pretreatment. McCoy cells was plated as described. After incubation at 37°C
overnight, 250 ng of iT N F-a (1 x 104 units) in 1 ml o f McCoy growth medium (5%)
was added to each vial. The vials were incubated at 37°C for 24 hours. The medium
containing rTN F-a was removed. Then, the pretreated cells were inoculated with CT
as described above. After inoculation, McCoy growth medium without rTN F-a (5%
FBS) was added to each vial. The vials were incubated at 37°C for 2 days.
After incubation at 37°C for two days, the cells were fixed and stained with
Johns’ iodine, then destaincd and reslained with FITC-conjugated anti-MOMP.
Meanwhile, CT recovery from lysates o f the infected cultures also was performed as
described.

Statistical Analysis
Student’s t test was used for comparison of means in two groups. Analysis of
Variance was used for comparison o f means in more than two groups. The Least
Significant Difference (LSD) was used to determine where the differences occurred if
a significant F is found. Linear Regression was used for analysis o f correlation
between nitrite production or NOS mRNA expression and CT inhibition.

CHAPTER 3
Results

Initial Inclusion Formation in CT-Infected
Macrophages and McCov Cells
Initial inclusions were formed in peritoneal macrophages infected by CT In
vitro, which was demonstrated by FITC-conjugated anti-MOMP antibody. However,
the pattern o f initial inclusion formation in peritoneal macrophages was quite different
from that in McCoy cells. The number o f inclusions in CT-infected peritoneal
macrophages reached a peak at 24 hr pi (4313 ± 273 inclusions /coverslip), then
continuously decreased during the period of observation (Figure 4). At day

6

pi, the

number of initial inclusions decreased to 340 ± 46 per coverslip. In contrast, in
McCoy cells 1917 ± 130 inclusions /coverslip were observed at 24 hr pi and
increased after 48 hr pi. The number o f inclusions reached a plateau (5481 ± 98
inclusions/coverslip) at day 4 pi which was sustained through day

6

(Figure 4). The

percentage o f infected peritoneal macrophages was 0.9% at 24 hr pi and decreased to
0.1% at day

6

pi (Table 2). However, the percentage o f infected McCoy cells was

0,2% at 24 hr pi and increased to 0.9% at day

6

pi.

CT Replication in Peritoneal Macrophages
In order to determine if CT replicated in peritoneal macrophages, recovery of
infectious CT (EBs) from infected cells was analyzed. CT recovery from lysates of
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Figure 4
Different patterns o f initial inclusion formation in CT-inoculated macrophages and McCoy cells.
Peritoneal macrophages and McCoy cells were inoculated with CT (M O I= l). Initial inclusions were
determined by FITC-conjugated anti-MOMP. Data presented are mean o f triplicate + S .D ..
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Table 2
PERCENTAGE OF CT-INFECTED CELLS
DURING IN VITRO INFECTION
%

Cell Type

Cells Infected

Days Post-infection
2

1

3

4

5

6

RAW264.7

0.1

< 0.1

0.3

0.4

0.5

0 .6

J774A.1

1.6

0 .6

9.8

12.1

27.4

48.2

M <f>

0.9

0.4

0.3

0 .2

0 .2

0.1

McCoy

0 .2

0 .2

0.3

0 .6

1.0

0.9

Peritoneal macrophages, RAW264.7, J774A. 1 and McCoy cells were inoculated
with CT (M O I= l). Infected cells were detected and enumerated by FITC-conjugated
anti-MOMP, at 48 hours pi.
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CT-infected peritoneal macrophages decreased from I0 6 IFU at the time o f inoculation
to 103 IFU at 24 hours pi (Figure 5). At 48 hours pi, CT recovery dramatically
increased to 2.8 x 104 IFU, which demonstrated replication. The shape o f curve of
CT recovery from infected macrophages was similar to that o f infected McCoy cells.
However, the level of CT recovery was two magnitudes lower than that from the
infected McCoy cells (Figure 5). CT recovery from coverslips without cells
(background control) decreased from 10* IFU at inoculation to 0 after 48 hours pi
(Figure 5).
The yield o f CT production (IFU/incIusion) in peritoneal macrophages reached
a peak between 48 and 72 hr pi and decreased thereafter. The pattern in McCoy cells
was similar to that in peritoneal macrophages (Figure 6 ), since the yield reached a
peak at 48 hr pi and decreased thereafter. However, the highest levels o f yield from
peritoneal macrophages were 21.2 (day 2) and 22.8 (day 3) IFU/inclusion, which was
significantly less than from McCoy cells (355 and 262 IFU/inclusion at days 2 and 3,
respectively). Thus the number of EBs produced by each inclusion was significantly
less in peritoneal macrophages than in McCoy cells.

Initial Inclusion Formation in Macrophage Cell Lines
Initial inclusion formation was demonstrated by FITC-conjugated anti-MOMP
stain in CT-infected macrophage cell lines (RAW264.7 and J774A.1). The number of
initial inclusions in CT-infected RAW264.7 was 908 ± 142 per coverslip at day 1 pi
and decreased at day 2 pi (419 ± 64 Inclusions/coverslip). At day 3 pi, the number

Figure 5
Kinetics o f CT recovery from peritoneal macrophages. Peritoneal macrophages and McCoy cells
were inoculated with CT (M O I= l). Addition o f inoculum to shell vials without cells served to define
background. CT recovery was quantitated at 0, 1.5, 10. 24, 48 and 72 hours pi, respectively in
susceptible McCoy cells. Data presented are mean o f triplicate ± S.D ..
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Comparative yield o f CT production in macrophages and McCoy cells. Peritoneal macrophages
and McCoy cells were inoculated with CT (M OI=2). Initial inclusions and CT recovery were
quantitated. Yield o f CT was determined fay a formula: N o. IFU/inclusion = No. IFU ml* / total initial
inclusions per coverslip. Data presented are mean o f triplicate ± S.D ..
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o f inclusions in RAW264.7 cells was increased (3000 ± 410 Inclusions/coversilp) and
maintained the same level thereafter (Figure 7). The number o f initial inclusions in
CT-infected J774A.1 cells was 9,521 ± 629 per coverslip at 24 hr pi. As in
RAW264.7 cells, the number o f initial inclusions in J774A.1 cells decreased at day 2
pi (3,771 ± 130 Inclusions/coverslip) but increased at day 3 pi (29,250 ± 1442
Inclusions/coverslip). However, the number o f initial inclusions in J774A.1 cells
gradually decreased after day 3 pi. The kinetics o f initial inclusions in peritoneal
macrophages was different from that in macrophage cell lines. The number o f initial
inclusions reached a peak at 24 hr pi and continuously decreased during the period of
observation (Figure 7). The pattern o f initial inclusion kinetics in McCoy cells was
similar to that in RAW264.7 cells with the exception that a decrease in the number of
initial inclusions was not observed at day 2 pi in the former (Figure 7).
The number of J774A.1 cells decreased by more than 80% after day 3 pi in
the infected cultures, but not in the infected RAW264.7 or McCoy cells (Figure 8 ).
As a result, the percentage o f infected cells at day 3 pi was 9.8% in J774A.1 cells
(Table 2). At day

6

pi, the percentage o f infected J774A. 1 cells was much higher

(48.2%) than that of infected RAW264.7 (0.6%) or McCoy cells (0.9%). As in
J774A.1 cells, the number o f peritoneal macrophages decreased by about 30% at day
6

pi. However, this decrease in cell number did not result in an increase in the

proportion of infected cells. In fact, the percentage of infected cells decreased from
0.9% at day 1 to 0.1% at day

6

pi (Table 2).

Figure 7
Comparison o f initial inclusion formation in macrophage cell lines and peritoneal macrophages.
Peritoneal macrophages, macrophage cell lines (RAW264.7 and J774A.1) and McCoy cells were
inoculated with CT (M O I=1). Initial inclusions were determined by FITC-conjugated anti-MOMP. Data
presented are mean o f triplicate ± S .D ..
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Comparative cell numbers in CT-infected cell lines. RAW264.7, J774A.1 and McCoy cells were
inoculated with CT (M O I=2). Number o f cells were estimated by using a light microscope at 400
magnification. Data presented are mean o f triplicate ± S.D ..

10 ® CO

-J

£3
U
r_

io ° -

o
rv
s

10

4

ZD
2 :

103

-

_L

e—3 RAW 2 6 4 .7 C ells
• J774A.1 C ells
McCoy C ells
*

1

2

3

4

£

DAYS P O S T -IN O C U L A T IO N

6

56
Effect of Medium Change Upon CT Replication
Since subsequent experiments would require addition o f inhibitors or cytokines
after infecton, it was important to determine the effect o f medium change upon CT
replication. The recovery o f CT from supernatants of CT-infected J774A.I cells was
355,278 ± 29,832 IFU/ml at day 2 pi. The highest recovery was at day

6

pi

(1,177,083 ± 81,570 IFU/ml). The level o f CT replication in McCoy cells was as
high as in J774A.1 cells (Fjgrue 9). CT recovery from McCoy cells was 322,361 ±
38,424 IFU/ml at day 2 pi. The highest recovery was at day 4 pi (885,444 ± 128,467
IFU/ml). In RAW264.7 cells, CT replication (214,028 ± 18,490 IFU/ml) was lower
than in McCoy cells (885,444 ± 128,467 IFU/ml), but higher than in peritoneal
macrophages (16,319 ± 8308 IFU/ml). Medium change significantly increased CT
replication in RAW264.7 (Figure 9A) and McCoy cells (Figure 9D). Medium change
did not affect CT replication in J774A.1 cells (Figure 9B), However, changing
medium daily actually decreased CT recovery in peritoneal macrophages (Figure 9C).

Inhibition o f CT Renlication bv LPS or IFN--V
The levels o f CT recovery from supernatants o f infected RAW264.7 cells were
1.2 x 10* and

6 .6

x 10* IFU/ml on days two and three, respectively. Figure 10A

shows that CT recovery from the supernatants was greatly reduced in IFN-y-treated
RAW264.7 cells (0,6 and 1.2 logs inhibition, p < 0 .0 1 determined by LSD). Greater
inhibition was observed in RAW264.7 cells treated with LPS (2.0 and 2.9 logs
inhibition, p < 0 .0 0 2 determined by LSD) or LPS plus IFN-y (2.4 and 4.8 logs

Figure 9
Effect of medium change upon CT replication. Peritoneal macrophages,
KAW264.7, J774A.1 and McCoy cells were inoculated with CT (M O I= l). In some
vials, maintenance medium was changed every 24 hours after inoculation. In others, the
medium was not changed. CT recovery from the supernatants o f infected cultures was
quantitated. Data presented are mean o f triplicate ± S.D ..
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inhibition, p < 0,002 determined by LSD). Significant inhibition by LPS or LPS plus
IFN-y appeared one day earlier than that by IFN-y alone (Figure 10A). Similar
decreases in intracellular CT recovery also were observed in lysates of RAW264.7
cells treated with IFN-y and/or LPS {data not shown).
In J774A.1 cells, CT recovery was dramatically inhibited (p < 0 .0 0 2
determined by LSD) by IFN-y- or LPS-treatment (Figure 10B). However, IFN-y
treatmcnt induced greater inhibition of CT recovery (1.7 logs) than LPS (0.9 logs).
IFN-y and LPS induced inhibition synergisticaliy (2.7 logs).
Inhibition of CT recovery was far less pronounced in IFN-y- and/or LPStreated McCoy cells than in the macrophage cell lines (Figure 10C). At day 3, LPS
slightly reduced CT recovery. IFN-y or IFN-y plus LPS exhibited significant
inhibition (0.3 and 0.4 logs o f inhibition, p < 0 .0 1 determined by LSD),

Nitrite Production Induced bv LPS or IFN-y
LPS or IFN-y induced significant nitrite production (p < 0.001 determined by
Student's t test) in uninfected RAW264.7 cell cultures without medium change (Figure
11), but nitrite production induced by LPS was higher. Peak nitrite production
occurred at 48 hr pt. Combination o f LPS and IFN-y exhibited a synergistic effect
upon nitrite production. No detectable nitrite production was observed in untreated
cells (Figure 11A). Medium changes every 24 hr pt dramatically reduced nitrite
production in the LPS- and/or IFN-y-trealed RAW264.7 cells (Figure I IB), indicating
that persistent stimulation was necessary for continued production o f nitrite.

Figure 10
Inhibition o f CT replication in cells treated with IFN -7 and LPS. CT-inoculated RAW264.7,
J774A.1 and McCoy cells (M O I= l) were treated with IFN-y (100 U/ml), LPS (100 ng/ml) or IFN-y
plus LPS at 24 hours pi. CT recovery was quantitated at days 1, 2 and 3 pt. Data are mean of triplicate
+ S.D ..
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Figure 11
Effect of medium change upon nitrite production in RAW264.7 cells. Uninfected RAW264.7
cells were treated with IFN -7 (100 U/ml), LPS (1 ^g/ml) or IFN -7 plus LPS. In some vials, the
maintenance medium was changed every 24 hours after treatment. In others, the medium was not
changed. Nitrite production was determined by the Griess reagent.
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Compared to RAW264.7 cells, J774A.1 (Figure 12) and McCoy cells (Figure
13) produced low levels of nitrite in response to LPS and IFN-y. The pattern of
nitrite production in J774A.1 cells treated with IFN-y and LPS was similar to that
observed in McCoy cells. The levels o f nitrite production in LPS-treatcd J774A. 1
cells were much higher than in McCoy cells.

LPS Dose Curve
In order to determine an optimal concentration o f LPS for stimulation of nitrite
production, increasing concentrations (from

0 .0 0 1

to

10

/tg/ml) were tested in

uninfected RAW264.7, J774A.1 and McCoy cells (Figure 14). As the concentration
o f LPS was increased from 0.001 /tg/ml to 0.1 /tg/ml, nitrite production
proportionally increased in RAW264.7 and J774A. 1 cells. Nitrite production reached
a plateau at 0,1 /tg/ml of LPS. Nitrite production was not remarkable in LPS-treatcd
McCoy cells, even at a concentration o f 10 /tg/ml. Therefore, the optimal
concentration of LPS for nitrite production in macrophage cell lines was 0.1 /tg/ml,
which was used in subsequent experiments.

Nitrite Production in CT-infectcd and Uninfected Cells
CT infection alone was not sufficient to induce nitrite production in
RAW264.7 (Figure 15B) or McCoy cells (Figure 16B). However, CT-infected
RAW264.7 cells treated with IFN-y produced more nitrite (17.6 ± 0.5 nmols/ml)
than uninfected RAW264.7 celts (6.9 ± 3.0 nmols/ml, Figure 15). CT-infected

Figure 12
Effect o f medium change upon nitrite production in J774A. 1 cells. Uninfected J774A. 1 cells
were treated with IFN - 7 (100 U/ml), LPS (1 /tg/ml) or EFN^y plus LPS. In some vials, the maintenance
medium was changed every 24 hours after treatment. In others, the medium was not changed. Nitrite
production was determined by the Griess reagent.
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Figure 13
Effect o f medium change upon nitrite production in McCoy cells. Uninfected McCoy cells were
treated with IFN - 7 (100 U/ml), LPS (1 /xg/ml) or IFN - 7 plus LPS. In some vials, the m a in te n a n c e
medium was changed every 24 hours after treatment. In others, the medium was not changed. Nitrite
production was determined by the Griess reagent.
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Figure 14
Uninfected RAW264.7, J774A. 1 and McCoy cells were treated with LPS (0.001,0.01, 0 .1 ,0 .5 ,
1 or 10 /ig/ml). At 48 hours pt, nitrite production was determined by the Griess reagent Data presented
are mean o f triplicate + S.D ..
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Figure 15
Comparison o f nitrite production in CT-infected and uninfected RAW264.7 cells. Uninfected or
CT-infected (MOI= 1) RAW264.7 cells were treated with IFN -7 (100 U/tnl), LPS (100 ng/mi) or IFN -7
plus LPS. Nitrite production was determined by the Griess reagent. Data presented are mean o f
triplicate ± S .D ..
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McCoy cells also produced more nitrite (4,1 nmol/ml) than uninfected cells (2.0
nmol/ml) following treated with IFN-y (Figure 16). Nitrite levels were the same in
CT-infected and uninfected cells treated with LPS or LPS plus IFN-y.

C orrelationQ rN itrileProdtictionandC T InhihitiQ n
RAW264.7 cells. A high level o f CT replication in the absence of nitrite
production was observed in untreated RAW264.7 cells (Figure 17A). IFN-y treatment
induced a high level of nitrite production (17.64 ± 0 .5 1 1 nm/ml) and inhibition of
CT replication (0.6 log reduction). LPS treatment induced a higher level o f nitrite
production (40.77 ± 1.598) and a 2 log (99%) inhibition of CT replication. The
highest levels of nitrite production (99.96 ± 6.376) and inhibition of CT replication
(2.4 logs) were observed in LPS- plus IFN-y-treated cells. Linear regression analysis
demonstrated a strong correlation between nitrite production and CT inhibition
(correlation coefficient: -0.93, P C 0.001, Figure 17A).
J774A.1 cells. A strong correlation (correlation coefficient; -0.94, P < 0.001)
also was observed between nitrite production and CT inhibition in J774A.1 cells
(Figure I7B). The slope o f the regression curve was slightly greater in J774A.1 cells
(2.453) than in RAW264.7 cells (2.061).

Figure 16
Comparison o f nitrite production in CT-infected and uninfected McCoy cells. Uninfected or CTinfected (M O I= l) McCoy cells were treated with EFN-7 (100 U/ml), LPS (100 ng/mi) or IFN -7 plus
LPS. Nitrite production was determined by the Griess reagent. Data presented are mean of triplicate
± S.D ..
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Figure 17
Correlation o f nitrite production and CT replication. RAW264.7, J774A. 1 and McCoy cells were
inoculated with CT (M OI=2). At 24 hours pi, infected cells were treated with EFN-y (100 U/ml), LPS
(100 ng/ral) or IFN -7 plus LPS. Nitrite production and CT recovery were determined at 48 hours pt.
Regression analysis o f nitrite production and CT recovery was performed.
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McCoy cells. Figure 17C shows the correlation of nitrite production and CT
inhibition in McCoy Cells (correlation coefficient: -0.67, P C 0.05). The slope o f the
regression curve was small (0.522).

Dose-dependent Effect o f L-NMMA upon
InhiMliQrLofNilritePrQduction
Since a combination o f LPS and IFN-y induced the highest level of nitrite
production in RAW264.7 cells, this combination was chosen to titrate the effect o f LNMMA upon nitrite production. At a concentration as low as 0.01 mM, L-NMMA
exhibited an inhibitory effect upon nitrite production (Figure 18). As the concentration
was increased from 0.01 to 10 mM, inhibition was increased proportionally. For
example, I mM L-NMMA inhibited 63-75% of nitrite production and 10 mM LNMMA inhibited 93-97% o f nitrite production. The L-NMMA dose curves at 24, 48
and 72 hours paralleled one another.

InhibitiQn_QfNitrite Production_bvL_L^NMMA in Uninfected Cells
Since 1 mM L-NMMA was shown to inhibit nitrite production in LPS- and
IFN-y-treatcd RAW264.7 cells (Figure 18), this concentration was used to test
inhibition o f nitrite production in uninfected RAW264.7, J774A.1 and McCoy cells
treated with LPS or IFN-y.
L-NMMA (1 mM) inhibited nitrite production by 74 or 85% at 24 hr pt in
RAW264.7 cells treated with LPS or IFN-y (Figure 19). Inhibition o f nitrite

Figure 18
Dose-dependent effect o f L-NMMA upon inhibition o f nitrite production in RAW264.7 cells
treated with IFN-y and LPS. Uninfected RAW264.7 ceils were treated with IFN-y (100 U/ml) and LPS
(100 ng/ml). At the time o f treatment, L-NMMA (0.001-10 mM) was added. Nitrite production was
measured at 24, 48 and 72 hours pt. Data presented are mean o f triplicate + S.D ..
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Figure 19
Inhibition o f nitrite production by L-NMMA in uninfected RAW264.7 cells. Uninfected
RAW264.7 cells were treated with IFN-y (100 U/mi), LPS (100 ng/ml) or IFN-y plus LPS. At the time
o f treatment, L-NMMA (1 mM) was added. Nitrite production was measured at days 1, 2 and 3. Data
presented are mean o f triplicate ± S .D ..
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production at 48 or 72 Itr pt (77 or 84%) was similar to that at 24 hr pt. Inhibition of
nitrite production induced by L-NMMA in RAW264.7 cells treated with LPS and
IFN - 7 was 81%, 75% and 76% at 24, 48 and 72 hr pt, respectively (Figure 19).
In J774A.1 cells, IFN - 7 induced a minimal level o f nitrite production. LNMMA did not significantly affect such low levels o f nitrite production (Figure 20).
LPS induced

8

and 13 nmol/inl o f nitrite at 2 and 3 days pt, respectively. L-NMMA

reduced this production to 3 and 4 nmol/ml (Figure 20). Inhibition o f nitrite
production induced by L-NMMA (1 mM) in LPS- and IFN-7 -treatcd J774A. 1 cells
was 56 and 73% at days 2 and 3, respectively (Figure 20),
In McCoy cells, LPS or IFN - 7 induced negligible levels o f nitrite production
at days 1 and 2 pt. L-NMMA (1 mM) did not significantly affect this production
(Figure 21). At day 3 pt, LPS or IFN - 7 induced 6.3 or 4.4 nmol/ml o f nitrite,
respectively. L-NMMA reduced this production to 2.3 nmol/ml. Inhibition o f nitrite
production induced by L-NMMA in LPS- and IFN-7 -treatcd McCoy cells was 85 and
86%

at 48 and 72 hours, respectively (Figure 21).

Inhibition of CT Infection bv rTNF-g in McCov Cells
To investigate the direct effect of TN F-a upon CT infection, iT N F-a was used
to treat McCoy cells before or after inoculation. TN F-a treatment after CT
inoculation significantly inhibited initial inclusion formation and CT replication (Table
3). T N F -a treatment caused development o f atypical inclusions which contained
unusually low levels o f glycogen. The latter were not detected when stained by

Figure 20
Inhibition o f nitrite production by L-NMMA in uninfected J774A.1 cells. Uninfected J774A.1
cells were treated with IFN-y (100 U/mi), LPS (100 ng/ml) or IFN-y plus LPS. At the time o f
treatment, L-NMMA (1 mM) was added. Nitrite production was measured at days I, 2 and 3. Data
presented are mean o f triplicate ± S .D ..
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Figure 21
Inhibition o f nitrite production by L-NMMA in uninfected McCoy cells. Uninfected McCoy cells
were treated with IFN -7 (100 U/ml), LPS (100 ng/ml) or EFN-7 plus LPS. At the time of treatment,
L-NMMA (1 mM) was added. Nitrite production was measured at days 1, 2 and 3. Data presented are
mean o f triplicate ± S .D ..
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Table 3
EFFECT OF TNFor UPON CT REPLICATION IN MCCOY CELLS
TNF-a
Pretreat

Post-inoc.
TNFa

Cyclohx.

—

—

Recovery

Yield*
EFU/Inclusion

Iodine

MAb-MOMP

(IFU/ml)

585 ±12

2,092±221

54,933±5,119***

26.3

—

100±9.9*

1,249±265**

13,500 ±3,984***

10.8

—

659±120

2,310±88

139,000±23,388

60.2

4,558±530

3,076±736

815,667± 178,240

265.2

_

—

Initial Inclusions

-r

CT-infected McCoy cells (M01=0.006) were treated with TNF-a (250 ng/ml) 24 hours before inoculation or immediately
after inoculation. Initial inclusions were determined by iodine or anti-MOMP stain at 48 hours pi. Concomitantly, CT recovery was
quantitated in susceptible McCoy cells. Untreated McCoy cells with or without cycloheximide (2 /rg/ml) served as controls. Data
(duplicate) presented are mean ± S.D.. * Yield computed from number o f inclusions enumerated by FTTC-and-MOMP.
** p < 0 .0 5 , *** p < 0 .0 l determined by Student's t test.

iodine, but were confirmed by staining with FITC-conjugated anti-MOMP antibody.
The inclusions in cells treated with TN F-a produced abnormally low numbers of
infectious EBs (10.8 IFU/inclusion) that is, the yield was lower than that in untreated
cells (60.2 IFU/inclusion). Pretreatment o f McCoy cells with T N F -a for 24 hr before
inoculation inhibited CT replication, but did not inhibit initial inclusion formation
(Table 3).

L-NMMA Did not Reduce TNF-a Production
Since TNF-a inhibited CT replication (Table 3) and LPS also is a strong
stimulator of TN F-a production (Jue et al. 1990), the effect of L-NMMA upon TNFa production was determined. No detectable TN F-a production was observed in
untreated cells (data not shown). IFN-y induced a very low level o f TN F-a
production in uninfected RAW264.7 cells (Figure 22A), but no detectable T N F -a in
J774A.1 cells (Figure 23A). LPS or LPS plus IFN-y induced a high level o f TN F-a
production in J774A. 1 cells (Figure 23B-C) and even higher levels in RAW264.7
cells (Figure 22B-C). Peak production occurred at approximately

6

hours pt (data not

shown) and remained in culture fluids for 72 hours. L-NMMA did not inhibit TN F-a
production. Rather, it somehow slightly increased TNF-a production in macrophage
cell lines treated with LPS or LPS plus IFN-y (Figure 22B-C, 23B-C). In McCoy
cells, LPS or LPS plus IFN-y did not induce TN F-a production (data not shown).
Therefore, it was not necessary to determine the inhibitory effect o f L-NMMA upon
TN F-a production in McCoy cells.

Figure 22
Effect o f L-NMMA upon TNF-a production in uninfected RAW264.7 cells. Uninfected
RAW 264.7 ceils were treated with IFN-7 (100 U/m l), LPS (100 ng/ml) or IFN-y plus LPS. At the time
o f treatment, L-NMMA (1 mM) was added. TNF-a production was measured at 6, 24, 48 and 72 hours
pt. Data presented are mean o f triplicate ± S.D ..
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Figure 23
Effect o f L-NMMA upon TNF-a production in uninfected J774A.1 cells. Uninfected J774A.1
cells were treated with IFN -7 (100 U/ml), LPS (100 ng/ml) or IFN-7 plus LPS. At the time of
treatment, L-NMMA (1 mM) was added. TNF-a production was measured at 6 , 24, 48 and 72 hours
pt. Data presented are mean o f triplicate ± S.D ..
A. IFN-7
B . LPS
C . L P S & IF N - t

A

B

C

W ith L-NMMA
W ith o u t. L-NMMA

0
1

io°-

fc-

2:

24

48

72 0

24

48

72 0

H O U R S P O S T -T R E A T M E N T

24

46

72

Correlation between Inhibition o f Nitrite Production
and .Abrogation o f CT Inhibition
The strong correlation between nitrite production and CT inhibition led us to
invoke the hypothesis that nitrite production was a mechanism o f CT inhibition. In
order to test this hypothesis, a series o f concentrations of L-NMMA (from 0.1 to 10
mM) was used to determine the correlation between inhibition o f nitrite production
and abrogation of CT inhibition. As expected, in the absence of L-NMMA, IFN - 7
and/or LPS induced high levels o f nitrite production (Figure 24) and inhibition of CT
replication in RAW264.7 cells (Figure 25), L-NMMA dramatically inhibited nitrite
production (Figure 24) and remarkably abrogated the inhibition o f CT replication in a
dose-dependent pattern (Figure 25). However, as the concentration o f L-NMMA was
increased from 5 mM to 10 mM, restoration o f CT replication was not increased.
Although 10 mM L-NMMA almost completely inhibited nitrite production, restoration
of CT replication was only 71% in IFN- 7 -treated RAW264.7 cells and 55% in LPStreated cells (Figures 24, 25). Furthermore, restoration o f CT replication induced by
L-NMMA in LPS-trealed RAW264.7 cells was less than that in IFN-7 -lreated cells.
Similar results were observed with CT-infected J774A.1 cells. As expected,
IFN - 7 or LPS induced nitrite production (Figure 26) and partial inhibition o f CT
replication by 0.7 and 1.9 logs, respectively (Figure 27). L-NMMA dramatically
inhibited nitrite production (Figure 26) and significantly abrogated inhibition o f CT
replication (Figure 27) in a dose-dependent pattern. L-NMMA (5 mM) increased CT
recovery by 0.9 logs and 1,4 logs in IFN - 7 or IFN - 7 plus LPS-treatcd J774A.1 cells,
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Figure 24
Inhibition o f nitrite production by L-NMMA in CT-infected RAW264.7 cells. CTinoculated RAW264.7 cells (M O I= l) were treated with IFN - 7 (100 U/ml), LPS (100
ng/ml) or IFN - 7 plus LPS at 24 hours pi. At the time o f treatment, L-NMMA (0.1, 1,
5 or 10 mM) was added. Nitrite production was measured at 48 hours pt. Data presented
are mean o f triplicate ± S.D ..
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Figure 25
Abrogation o f CT inhibition by L-NMMA in RAW264.7 cells. CT-inoculated
RAW264.7 cells (M O I= l) were treated as described in Figure 24. At 48 hours pt, CT
recovery was quantitated. Data presented are mean o f triplicate ± S.D .,
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Figure 26
Inhibition of nitrite production by L-NMMA in CT-infected J774A.1 cells. CTinoculated J774A.1 cells (M O I= l) were treated with IFN-y (100 ll/m l), LPS (100
ng/ml) or IFN - 7 plus LPS at 24 hours pi. At the time o f treatment, L-NMMA (0.1, 1
or 5 mM) was added. Nitrite production was measured at 48 hours pt. Data presented
are mean o f triplicate ± S.D ..
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Figure 27
Abrogation of CT inhibition by L-NMMA in J774A.1 cells. CT-inoculated
J774A.1 cells (M O I= l) were treated as described in Figure 26. At 48 hours pt, CT
recovery was quantitated. Data presented are mean of triplicate ± S.D ..
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respectively. However, this increased recovery approached the untreated control by
only 9.5% and 6.3%. In contrast, restoration induced by L-NMMA in LPS-treated
cells (5 mM) was 52% {Figures 26, 27).
In CT-infectcd McCoy cells, neither significant nitrite production nor CT
inhibition was observed by treatment with LPS (Figures 28-29). IFN-y or IFN-y plus
LPS induced low levels o f nitrite production (Figure 28) and concomitant inhibition of
CT replication by 1.3 and 1.4 logs IFU/ml, respectively (Figure 29). L-NMMA
significantly increased CT replication by 1.5- or twofold (p < 0 .0 5 determined by
Student’s t test) in IFN-y- or IFN-y plus LPS-treated cells. However, restoration o f
CT replication was only 7-9%. Furthermore, as the concentration of L-NMMA was
increased from 0.1 to 5 mM, no further increase in CT replication was observed in
these cells (Figure 29), although inhibition of nitrite production continued to increase.

In a separate but similar experiment, IFN-y or IFN-y plus LPS induced lower nitrite
production and less inhibition of CT replication in McCoy cells (data not shown). LNMMA did not affect CT replication in the cells treated with IFN-y or IFN-y plus
LPS (data not shown).

Nitrite Did Not Inhibit CT Replication in RAW264.7 Cells
Since our previous results suggested that nitrite production may be a
mechanism for inhibition of CT replication in RAW264.7 cells, it was necessary to
determine if nitrite served as the effector molecule. CT-infecled RAW264.7 cells
were treated with nitrite (concentrations from 50 to 200 nmol/ml). This treatment
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Figure 28
Inhibition o f nitrite production by L-NMMA in CT-infectcd McCoy cells. CTinoculated McCoy cells ( M O I - 1) were treated with IFN - 7 (100 U/ml), LPS (100 ng/ml)
or IFN - 7 plus LPS at 24 hours pi. At the time o f treatment, L-NMMA (0,1, 1 or 5 mM)
was added. Nitrite production was measured at 48 hours pt. Data presented arc mean of
triplicate ± S.D..
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Figure 29
Abrogation o f CT inhibition by L-NMMA in McCoy cells. CT-inoculated McCoy
cells (M O I= 1) were treated as described in Figure 28. At 48 hours pt, CT recovery was
quantitated. Data presented arc mean o f triplicate ± S.D ..
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Figure 30
Effect o f nitrite upon CT replication in RAW264.7 ceils. CT-inoculated RAW264.7 cells
(M O I= l) were treated with sodium nitrite (50-200 nmol/ml) at 24 hours pi. CT recovery was
quantitated at 48 hours pt. Data presented are mean o f triplicate ± S.D ..
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neither affected TN F-a production (data not shown) nor inhibited CT replication
(Figure 30), indicating that nitrite probably is not an effector molecule involved in
inhibition o f CT replication.

Kinetics o f NOS mRNA Expression in RAW264.7 Cells
NO is a mediator of nitrite production but is difficult to measure because o f its
short half life (several seconds). Therefore, NOS mRNA was measured by Northern
blot hybridization with a NOS-cDNA probe. Total RNA was isolated from uninfected
or CT-infected RAW264.7 cells which had been treated with LPS and/or IFN- 7 .
Figure 31 shows total RNA following electrophoresis on a formaldehyde-denaturing
agarose gel (1%) stained with cthidium bromide. Similar bands of 18S and 28S rRNA
were exhibited in all samples isolated front uninfected, infected and treated cells.
Figure 32 shows the results o f a Northern blot hybridization. No detectable NOS
mRNA expression was observed in uninfected or CT-infected cells which had not
been treated (Lanes a, b). In CT-infected RAW264.7 cells, IFN - 7 (Lanes c, g & k),
LPS (Lanes d, h & I) or IFN - 7 plus LPS (Lanes e, i & m) induced low, intermediate
and high levels o f NOS ntRNA expression, respectively. Anti-TNF-a antibody did not
reduce NOS mRNA expression induced by LPS at any of the time points tested
(Lanes f, j & n). Peak expression occurred at 6-24 hr pt (Lanes c-j). Expression o f
mRNA was diminished at 48 hours pt (Lanes k-n) in IFN- 7 - and/or LPS-treated cells.
Therefore,

6

hr was chosen as the time point to determine NOS mRNA expression in

subsequent experiments.
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Figure 31
Total RNA isolated from RAW264.7 cells. Lane a, uninfected; Lane b-n, CTinfected (M O I= l); Lane b, CT-infected alone (24 hours pi); Lanes c, g and k, IFN-7 treated (100 U/ml); Lancs d, h and 1, LPS-treated (100 ng/ml); Lanes e, i and m, IFN- 7 and LPS-treated; Lanes f, j and n, LPS- and anti-TNF-a Ab-treated; Lanes c, d, e and
f, 6 hours pt; Lanes g, h, i and j, 24 hours pt; Lanes k, 1, m and n, 48 hours pt. 10 pg
of total RNA loaded onto each lane. Elhidium bromide-stained formaldehyde denaturing
196 agarose gel.
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Figure 32
Kinetics o f NOS mRNA expression in RAW264.7 cells. Lane a, uninfected;
Lanes b-n, CT-infected (M O I= 1); Lane b, CT-infected alone (24 hours pi); Lanes c, g
and k, IFN- 7 -treated (100 U/ml); Lancs d, h and 1, LPS-treated (100 ng/ml); Lanes e,
i and m, IFN- 7 - and LPS-treated; Lanes f, j and n, LPS- (100 ng/ml) and anti-TNF-a
Ab-treated; Lanes c, d, e and f, 6 hours pt; Lanes g, h, i and j, 24 hours pt; Lanes k,
I, m and n, 48 hours pt. Total RNA (10 jtg) was electrophoresed on formaldehyde
denaturing 1% agarose gel, transferred onto Nytran plus nylon membrane, and
hybridized with [” P]-labcled NOS cDNA. XAR-5 X-ray film was exposured to this
membrane for 24 hours. Size markers (in kilobases) are given at left.
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Correlation between NOS mRNA Expression and
CT Inhibition in RAW264.7 Cells
Total RNA was isolated from CT-infected RAW264.7 cells treated for

6

hours

with LPS and/or IFN-y. NOS mRNA expression was determined by Northern and dot
blot hybridization. Both the Northern (Figure 33A) and the dot blot (Figure 34A)
hybridizations showed that low, intermediate and high levels o f NOS mRNA
expression were induced by IFN-y, LPS or IFN-y plus LPS, respectively. CT
infection alone (without IFN-y or LPS) did not induce delectable NOS mRNA
expression, which was consistent with the observed lack of nitrite production in these
cells. Control hybridization with a 0-aclin cDNA probe showed that similar amounts
of RNA from each sample were used (Figures 33B, 34B). Concomitantly, CT
recovery at 48 hours pt was analyzed. As expected, CT replication was dramatically
inhibited by LPS and/or IFN-y treatment. Densities of NOS mRNA dots from the dot
Blot hybridization was used for correlation analyses. Figure 35 shows a strong
correlation between density of NOS mRNA dots and inhibition o f CT replication
(correlation coefficient: -0.97, P < 0 .0 5 determined by Linear Regression).

Effect of Anti-TNF-pf Ab upon NOS mRNA Expression. Nitrite Production
and CT Replication in RAW264.7 Cells
In order to explore the effects of TN F-a upon nitrite production and CT
inhibition, polyclonal anti-TNF-a Ab (neutralizing Ab) was employed. As expected,
IFN-y, LPS or both induced nitrite levels in RAW264.7 cells of 47, 60 and 130
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Figure 33A
Effect o f anti-TNF-a antibody upon NOS mRNA expression in CT-infected
RAW264.7 cells (M 0 1 = l). Lanes a-d, untreated; Lanes e-h, IFN-y-lreated (100 U/ml);
Lanes i-1, LPS-treated (100 ng/ml); Lanes m-p, IFN-y- and LPS-treated; Lanes b, f, j
& n, anti-TNF-a Ab-treated; Lanes c, g, k & o, L-NMMA-treated (ImM ); Lanes d, h,
1 & p, L-NMMA- and anti-TNF-a Ab-trealcd. Total RNA (10 /tg) was isolated at 6
hours pt, electrophoresed on formaldehyde denaturing 1 % agarose gel, transferred onto
Nytran plus nylon membrane, and hybridized with [” P]-labeled NOS cDNA probe.
XAR-5 X-ray film was exposured to the membrane for 24 hours. Size markers (in
kilobases) are given at left.
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Figure 33B
Control hybridization by j3-actin cDNA probe in CT-infected RAW264.7 cells
(M O I= l). Lanes a-d, untreated; Lanes e-h, IFN- 7 -lreated (100 U/ml); Lanes i-1, LPStreated (100 ng/ml); Lanes m-p, IFN- 7 - and LPS-treated; Lanes b, f, j & n, anti-TNF-a
Ab-treated; Lanes c, g, k & 0 , L-NMMA-treated (Im M ); Lanes d, h, 1 & p, L-NMMAand anti-TNF-a Ab-treated. The membrane used for hybridization with NOS cDNA
probe in Figure 33A was washed and rehybridized with [^PJ-labeled 0-actin cDNA
probe. XAR-5 X-ray film was exposured to this membrane for 48 hours. Arrows at left
indicate NOS mRNA and 0-actin mRNA, respectively.
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Figure 34A
Effect of anti-TNF-a antibody upon NOS mRNA expression in CT-infected
RAW264.7 cells (M O I« l). A1-I0, IFN- 7 - (100 U/ml) and LPS-treated (100 ng/ml),
total RNA 4, 2, 1, 0.5, 0.25,0.125 , 0.062, 0.031, 0.016, 0.008 pg, respectively; A ll,
4 pg RNA (from IFN- 7 - and LPS-treated cells) treated with RNase (40 pg); B l-4,
untreated; B5-8, IFN- 7 -treatcd (100 U/ml); C l-4 , LPS-treated (100ng/ml); C5-8, IFN-yand LPS-treated; B2, B 6 , C2 & C 6 , anti-TNF-a Ab-treated; B3, B7, C3 & C7, LNMMA-treated (ImM ); B4, B 8 , C4 & C 8 , L-NMMA-and anti-TNF-a Ab-treated. Total
RNA (1 pg) was isolated at 6 hours pt, blotted onto Nytran plus nylon membrane and
hybridized with [31P]-labeled NOS cDNA probe. XAR-5 X-ray film was exposured to this
membrane for 48 hours.
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Figure 34B
Control Hybridization by /?-Actin cDNA Probe in CT-infected RAW264.7 cells
(M O I= l). A l-10, IFN-y- (100 U/ml) and LPS-treated (100 ng/ml), total RNA 4, 2, 1,
0.5, 0.25, 0.125, 0.062, 0.031, 0.016, 0.008 pg, respectively; A l l , 4 pg RNA (from
IFN-y- and LPS-treated cells) treated with RNase (40 pg); B l-4, untreated; B5-8, IFN-ytreated (100 U/ml); C l-4 , LPS-treated (100 ng/ml); C5-8, IFN-y- and LPS-treated; B2,
B6 , C2 & C 6 , anti-TNF-a Ab-treated; B3, B7, C3 & C7, L-NMMA-treated (ImM ); B4,
B8 , C4 & C 8 , L-NMMA- and anti-TNF-a Ab-treated. Total RNA (1 pg) was isolated
at 6 hours pt, blotted onto Nytran plus nylon membrane and hybridized with pP]-labeled
0-actin cDNA probe. XAR-5 X-ray film was exposured to this membrane for 48 hours.
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Figure 35
Inverse correlation between NOS mRNA expression and CT replication in RAW264.7 cells. CTinoculated RAW 264.7 cells (M OI= 1) were treated with IFN -7 (100 U/m l), LPS (100 ng/ml) or IFN -7
plus LPS at 24 hours pi. Total RNA was isolated at 6 hours pt and hybridized with [^P]-labeled NOS
cDNA probe as shown in Figure 34A. The density o f the dots was measured by Bio-Image Analysis
System. CT recovery was quantitated at 48 hours pt. Regression analysis o f CT recovery and density
o f dot blot hybridization was performed.
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nmol/ml, respectively (Figure 37). L-NMMA inhibited nitrite production by 85%,
86%

and 76%. TN F-a production in LPS- or LPS- plus IFN-y-treated cells was 3123

and 1753 units/ml, respectively. Although anti-TNF-af antibody neutralized TN F-a
biological activity in LPS- and/or IFN-y-treated cells (Figure 36), the antibody did
not inhibit NOS mRNA expression (Figure 33A, 34A) or nitrite production (Figure
37). The antibody slightly reduced nitrite production (from 130.3+4.3 to 117.4+4.5
nmol/ml) in LPS- and IFN-y-treated cells (Figure 37). As expected, L-NMMA (1
mM) did not affect NOS mRNA expression (Figure 33A, 34A), Combination of the
antibody and L-NMMA did not greatly affect inhibition o f nitrite production by LNMMA (Figure 37).
As expected, treatment with LPS, IFN-y or both inhibited CT replication by
1.6 logs, 1.3 logs or 2.6 logs, respectively, L-NMMA (1 mM) partially restored CT
replication (21% with LPS, 39% with IFN-y or

8

% with IFN-y plus LPS). The

antibody alone did not abrogate this inhibition. However, combination of the antibody
with L-NMMA increased the restoration (Figure 38), particularly in cells treated with
LPS (42%) or LPS plus IFN-y (17%, p < 0 .0 1 determined by Student’s t test).

Relationship between Nitrite Production and CT Replication
in Peritoneal Macrophages
As in previous experiments with macrophage cell lines, peritoneal
macrophages were induced by LPS to produce TN F-a (Figure 39). However, the
levels o f TN F-a were lower (39 units/ml) than in the macrophage cell lines. No

Figure 36
Specific antibody neutralizes TN F-a produced by CT-infected RAW264.7 cells. CT-inoculated
RAW 264.7 cells (M O I= l) were treated with IFN -y (100 U/m l), LPS (100 ng/ml) or IFN-y plus LPS
at 24 hours pi. At the time o f treatment, anti-TNF-a antibody was added. TNF-a biological activity was
measured at 48 hours pt by biological assay in L929 cells (see Materials and Methods for detail). Data
presented are mean o f triplicate + S .D ..
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Figure 37
Effect o f anti-TNF-a antibody and L-NMMA upon nitrite production in CT-infected RAW 264.7
cells. CT-inoculated RAW 264.7 cells (M O I= l) were treated with IFN -7 (100 U/m l), LPS (100 ng/ml)
or IFN -7 plus LPS at 24 hours pi. A t the time o f treatment, anti-TNF-a antibody, L-NMMA (1 mM)
or the antibody plus L-NMMA was added. Nitrite production was determined at 48 hours pt by the
Griess reagent. Data presented are mean o f triplicate + S .D ..
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Figure 38
Effect o f anti-TNF-a antibody and L-NMMA upon CT recovery in RAW264.7 cells. CTinoculated RAW 264.7 cells (M O I= l) were treated as described in Figure 37. CT recovery was
quantitated at 48 hours pt in susceptible McCoy cells. Data presented are mean o f triplicate ± S .D ..
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detectable TN F-a production was observed at 48 hr in CT-infected peritoneal
macrophages treated with IFN-y (Figure 39). Anti-TNF-a antibody completely
neutralized the biological activity o f TN F-a secreted by peritoneal macrophages
treated with LPS or LPS plus IFN-y (Figure 39).
As shown in Figure 40, levels o f nitrite production in peritoneal macrophages
treated with IFN-y, LPS or both (33, 36 and 72 nmol/ml, respectively) were
comparable to those in macrophage cell lines (Figure 37). No detectable nitrite
production was observed in untreated peritoneal macrophages (Figure 40) or
RAW264.7 cells (Figure 37). As expected, L-NMMA dramatically inhibited nitrite
production (Figure 40). The inhibition o f nitrite production induced by L-NMMA (1
mM) was more pronounced in peritoneal macrophages treated with IFN - 7 or LPS
(93% with IFN - 7 and 100% with LPS) than in RAW264.7 cells (8 6 % with IFN-y and
87% with LPS). In contrast to RAW264.7 cells, nitrite production in peritoneal
macrophages was inhibited by anti-TNF-a antibody (Figure 40). Levels of inhibition
induced by the antibody in the macrophages treated with LPS, IFN - 7 or both were
64%, 73% and 23% , respectively. Combination of antibody with L-NMMA slightly
enhanced inhibition of nitrite production (Figure 40).
Treatment of peritoneal macrophages with IFN- 7 , LPS or LPS plus IFN - 7
inhibited CT replication by 1.1, 1.2 and 1,9 logs, respectively (Figure 41). AntiTN F-a antibody significantly increased CT replication from 478 to 1822 IFU (34%
restoration) in peritoneal macrophages treated with IFN-y. L-NMMA also restored
CT replication to 2755 IFU (35%) in these cells. Combination o f the antibody and L-

Figure 39
Specific antibody neutralizes TN F-a produced by CT-infected peritoneal macrophages. CTinoculated peritoneal macrophages (M O I=2) were treated with IFN-y (100 U/m l), LPS (100 ng/ml) or
IFN-y plus LPS at 24 hours pi. At the time o f treatment, anti-TNF-a antibody was added. TN F-a
biological activity was measured at 48 hours pt by biological assay in L929 cells (see Materials and
Methods for detail). Data presented are mean o f triplicate + S .D ..
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Figure 40
Effect o f anti-TNF-a antibody and L-NMMA upon nitrite productionin in CT-infected peritoneal
macrophages.CT-inoculated peritoneal macrophages (M O I=2) were treated with IFN-y (100 U /m l),
LPS (100 ng/ml) or IFN-y plus LPS at 24 hours pi. At the time o f treatment, anti-TNF-a antibody, LNMMA (1 mM) or the antibody and L-NMMA was added. Nitrite production was determined at 48
hours pt by the Griess reagent. Data presented are mean o f triplicate ± S .D ..
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Figure 41
Effect o f anti-TNF-a antibody and L-NMMA upon CT replication in CT-infected peritoneal
macrophages. CT-inoculated peritoneal macrophages (M O I=2) were treated as described in Figure 40.
At 48 hours pt, CT recovery was quantitated in susceptible McCoy cells. Data presented are mean o f
triplicate ± S .D ..
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NMMA did not enhance the restoration of either. L-NMMA significantly (P < 0 .0 5
determined by Student’s t test) increased CT replication from

88

to 700 IFU ( 8 . 6 %

restoration) in peritoneal macrophages treated with IFN-y and LPS, yet anti-TNF-a
antibody did not restore replication (Figure 41). In LPS-treated peritoneal
macrophages, neither L-NMMA nor the antibody significantly restored CT replication
(Figure 41). In contrast to RAW264.7 cells, anti-TNF-a antibody significantly
inhibited nitrite production (73%) and partially reversed inhibition o f CT replication
(34%) in IFN-y-treated peritoneal macrophages. Anti-TNF-a antibody alone had no
effect upon nitrite production or CT replication in RAW264.7 cells. L-NMMA did
not reverse inhibition of CT replication in LPS-treated peritoneal macrophages, but it
did so in RAW264.7 cells. A final observation was that restoration o f CT replication
by L-NMMA was less pronounced in peritonea! macrophages treated with IFN-y than
in RAW264.7 cells.

IFN-ar and LPS Did Not Inhibit CT Replication
in QVCAR-3 or RLE Cells
OVCAR-3 and KLE cells did not respond to IFN - 7 and LPS by producing
nitrite or TN F-a (data not shown). These cell lines were used to test the effect of LPS
and IFN - 7 upon CT replication in susceptible genital epithelial cells. Treatment with
LPS and IFN-y did not effect inhibition o f CT replication in these cells (Figure 42).
Therefore, studies with L-NMMA or anti-TNF-a antibody were not conducted.

Figure 42
IFN -7 and LPS do not inhibit CT replication in KLE or OVCAR-3 cells. KLE or OVCAR-3
cells were inoculated with CT (M O I= 1). At 24 hours pi, infected cells were treated with DFN-7 (100
U /m l), LPS (100 ng/ml) or IFN -7 plus LPS. At 48 hours pt, CT recovery was quantitated in susceptible
McCoy cells. Data presented are mean o f triplicate ± S .D ..
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Tryptophan Did Not Abrogate Inhibition o f CT Replication
To determine if the tryptophan degradation pathway was involved in the
inhibition of CT replication in our system, increasing concentrations (40-1000 /ig/ml)
were added to CT-infected RAW264.7 cells treated with LPS and IFN-y. Tryptophan
slightly increased T N F -a production (data not shown). However, tryptophan did not
affect inhibition o f nitrite production by L-NMMA in LPS- and IFN-y-treated
RAW264.7 cells except at a high concentration (1000 /xg/ml) where nitrite production
was slightly diminished (Figure 43). As expected, CT replication was inhibited by
LPS and IFN-y and was partially restored by the addition o f 1 mM L-NMMA (Figure
44). Tryptophan (40-1000 /ig/ml) alone did not abrogate inhibition o f CT replication
nor did tryptophan, when combined with L-NMMA, enhance restoration of CT
replication (Figure 44).

Figure 43
Effect o f tryptophan upon nitrite production in CT-infected RAW 264.7 cells stimulated by IFN -7
and LPS. CT-inoculated RAW 264.7 cells (M O I= 1) were treated with IFN -7 (100 U/ml) and LPS (100
ng/ml) at 24 hours pi. At the time o f treatment, tryptophan (40-1000 jig/m l) or tryptophan plus LNMMA (1 mM) was added. At 48 hours pt, nitrite production was determined by the Griess reagent.
Data presented are mean o f triplicate ± S .D ..
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Figure 44
Effect o f tryptophan upon CT replication in RAW 264.7 cells stimulated by IFN-y and LPS. CTinoculated RAW 264.7 cells (M O I= l) were treated as described in Figure 43. At 48 hours pt, CT
recovery was quantitated in susceptible McCoy cells. Data presented are mean o f triplicate ± S .D ..
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CHAPTER 4
Discussion

CT Infection o f Macrophages
Infection of macrophages by CT biovar trachoma has not been confirmed (Kuo
1978, Yong 1987, Ishikawa et al. 1986, Keat et al. 1987). In this study, we showed
that CT serovar D infected mouse peritoneal macrophages to form initial inclusions.
However, the number o f initial inclusions decreased from 4313 at day 1 pi to 340
inclusions per coverslip at day

6

pi (Figure 4). The percentage o f infected cells

decreased from 0.9% to 0.1 % as well (Table 2). In contrast, the number o f initial
inclusions and percentage o f infected cells increased in McCoy cells (Figure 4, Table
2), which presumably was due to secondary infection o f new cells by the EBs released
from the infected cells. These data indicated that primary infection occurred in
macrophages while secondary infection was limited. TN F-a production by
macrophages exposed to CT (our unpublished data) may be an explanation for
inhibition o f secondary infection, but the precise mechanism is unknown. On the other
hand, the number o f inclusions at 24 hours pi was much higher in macrophages than
in McCoy cells (Figure 4), suggesting that chlamydial entry may be more efficient in
macrophages than in McCoy cells. Professional phagocytosis by macrophages may
mediate entry o f the organisms. Since all steps involved in the CT developmental
cycle, including attachment, ingestion, reorganization o f EB to RB or RB maturation
to EB, can affect inclusion development (Moulder 1991), other factors may have
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contributed to this phenomenon.
Recovery o f CT from infected macrophages was low (Figure 5). A low level
o f CT recovery also was observed by Kuo (1978). However, it was not clear whether
K uo's result reflected a low level o f CT replication or residual inoculum. Our data
confirmed that CT replicated in macrophages since (a) CT recovery from
macrophages was much higher than that o f background (residual inoculum) and (b) a
kinetic study demonstrated increase o f CT recovery from 48 hr pi through
(Figures

6,

6

days

9C). However, the level o f CT replication in macrophages was lower than

in McCoy ceils, as evidenced by lower level o f CT recovery and lower yield (Figure
6 ).

CT replicated in macrophages less efficiently than in McCoy cells, indicating that

CT replication in peritoneal macrophages was limited at some step o f the
developmental cycle beyond entry since the number of initial inclusions at 24 hr pi
was greater in macrophages than in McCoy cells.
CT Infection o f Macrophage Cell Lines
CT biovar trachoma (serovar D) infected mouse macrophage cell lines
RAW264.7 and J774A.1 to form initial inclusions (Figure 7). The number o f initial
inclusions decreased at day

2

pi, then increased at day 3 pi, presumably due to

secondary infection as observed in McCoy cells. However, the increase o f initial
inclusions in macrophage cell lines occurred one day earlier than in McCoy cells (day
4 pi), which suggested that the CT developmental cycle in macrophage cell lines may
be shorter than in McCoy cells. The number o f cells significantly decreased (Figure
8)

and the percentage o f infected cells dramatically increased (Table 2) in CT-infected
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J774A.1 cell cultures, suggesting that CT infection may result in lysis o f J774A.1
cells. As in fresh peritoneal macrophages, the number of initial inclusions at 24 hours
pi was higher in J774A.1 than in McCoy cells (Figure 7), again suggesting that
professional phagocytosis may mediate entry o f the organisms.
Recovery o f CT from macrophage cell lines was low at day 1, then increased
after day 2 (Figure 9), which demonstrated that CT replicated in the lines. The levels
o f CT replication in macrophage cell lines were higher than in peritoneal macrophages
(Figure 9). The level o f the replication in J774A.1 cells was even higher than in
McCoy cells (Figure 9), indicating that CT not only entered J774A.1 cells
successfully but replicated efficiently. The reason J774A.1 cells were so susceptible to
CT infection is not clear. This line was reported to secrete 1L-1 continuously (ATCC
1988). IL-1 secretion is enhanced by LPS treatment (Martin and D orf 1990).
Secretion o f IL-1 also may be increased in response to CT infection. In this regard,
IL-1 production in human monocytes was induced by CT (Manor et al. 1990,
Rothermel et al. 1989). A detectable level of TNF-a production in CT-infecled
J774A.1 cells also was observed in our study. IL-1 and TNF-a should have provided
J774A.1 cells some level o f protection against CT infection, since these cytokines
have been reported to inhibit CT infection (Shemcr-Avni et al. 1988, 1989, 1990,
Holtmann et al. 1990). It is possible that the level of IL-1 or TNF-a did not reach
"threshold" for inhibition of CT replication or that J774A.I cells did not respond to
those cytokines by exhibiting antichlamydial activity. In fact, it has been observed that
J774A.1 cells did not respond to IL-1 or TNF-a by producing 1L-6, implying that
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these cytokines may not he autoregulatory for (his macrophage cell line (Martin and
D orf 1990). This line also synthesizes large amounts of lysozyme (ATCC 1988). The
significance of the latter during CT infection is unclear.
Medium change every 24 hours significantly increased CT recovery from
RAW264.7 and McCoy cells, presumably by providing the infected cells with fresh
medium, optimal pH and new nutrients. However, medium change in J774A.1 cells
did not increase recovery (Figure 9), This may have contributed to destruction or lysis
o f the majority of cells after CT infection (Figure 8 ). The remaining cells were so
few that the medium did not become acid and nutrients presumably were sufficient to
support CT replication. CT recovery from peritoneal macrophages gradually
decreased after day 4. Medium change did not increase CT recovery. Rather, a
decrease o f CT recovery was observed (Figure 9). This may be due to limited
secondary infection of peritoneal macrophages and removal o f released Ells by
medium change.
Macrophage cell lines RAW264.7 and J774A.1 share several features with
fresh macrophages such as phagocytic activity, antibody-dependent cytotoxicity and
cytokine production in response to LPS or IFN-y stimulation (ATCC 1988, Jue et al.
1990, Radotf et al. 1991, Kelly et al. 1991, Oh et al. 1991, Martin and Dorf 1990,
Lewis et al. 1990). However, (he macrophage cell lines have long life spans in tissue
culture and are more susceptible to CT infection than fresh macrophages. Therefore,
they may be ideal cell lines for study of interaction between macrophages and CT in

yilm.
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Inhibition of CT Rcplicalion bv LPS orJFN -'y
Inhibition of Chlamydia psittaci, CT LGV ami other microorganisms by IFN7 -activalcd

macrophages has been demonstrated (Rolhermel el al. 1983, dc la Maza ct

al. 1987, Shemcr and Sarov 1985, Green et al. 1990, Granger et al. 1990, Adams et
al. 1990). In this study, wc demonstrated that IFN-y- or LPS*activated macrophage
cell lines RAW264.7 and J774A.1 restricted CT replication (Figure 10). Inhibition
induced by LPS was greater than that by IFN - 7 in RAW264.7 cells. However, LPS
was less effective in inducing inhibition o f CT replication than IFN - 7 in J774A.1
cells. This result may reflect different mechanisms involved in inhibition in different
cell types. Activation of macrophages for microbicidal and lumoricidal activities is
thought to be a two signal process (Celada cl al. 1984, Pace et al. 1983, Nacy ct al.
1988). However, our data and that of others (Rothcrmel et al. 1983, dc la Maza et al.
1987, Shemcr and Sarov 1985, Byrne et al. 1989) indicated that IFN - 7 or LPS was
sufficient to induce antichlamydial activity in Cl'-infected peritoneal macrophages.
Possibly, chlamydial LPS or the infection itself somehow primed the cells. In this
case, IFN-y or LPS served as a second signal to trigger antichlamydial activity in
these cells. Two signals such as IFN - 7 and LPS did enhance inhibition o f CT
replication in RAW264.7 and J774A.1 cells (Figure 10). Inhibition of CT replication
also was observed in McCoy cells treated with IFN-y and LPS (Figure 10). However,
the inhibition was less pronounced, compared to macrophage cell lines.
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Nilrilc Production in CT-in fee ted and Uninfected Cells
The inechanism(s) fur inhibition of CT replication in activated macrophages
have not been defined. In this study, we focused upon nitrite production as a possible
mechanism. Our data showed that nitrite production was induced by IFN - 7 or LPS in
macrophage cell lines RAW264.7 and J774A.1 (Figures 11-12). However, the levels
of nitrite production induced by IFN-y were lower than that induced by LPS,
particularly in J774A.1 cells. Lower nitrite production ( < 10 nmol/HP cells) was
observed by others (Stuehr and Marietta 1987b) in IFN-y-trealed J774A.1 cells than
in peritoneal macrophages. This may be related to the report that macrophage cell
lines expressed fewer receptors for IFN-y than primary macrophages (Cclada at cl.
1984). Nitrite production induced by LPS or LPS plus IFN-y was greater in
RAW264.7 cells than in J774A.I cells. This may be related to a high level o f TN F-a
production in the treated RAW2G4.7 cells (Figure 22B-C). IFN-y and LPS exhibited a
synergistic effect upon nilrilc production (Figures 11-12). Synergistic effects were
exerted by LPS and IFN-y or by LPS and lymphokines (Stuehr and Marietta 1987b).
They also observed (hat other stimuli such as lymphokines, BCG (bacillus of Calmettc
and Guerin) or PPD (purified protein derivative o f old tuberculin) induced nitrite
production in RAW264.7 cells, but not in J774A.I celts (Stuehr and Marietta 1987b).
The peak production of nitrite was 48 hours pt. No detectable nitrite production was
observed in untreated cells.
Our data indicated (hat the presence of IFN-y and/or LPS was necessary for
persistent production of nitrite, since medium change resulted in a significant
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reduction o f nitrite production (Figure 11B, 12B). But, Stuehr and Marietta (1987a)
reported that after peritoneal macrophages were treated with IFN - 7 and/or LPS, daily
medium change (without IFN - 7 or LPS) significantly increased nitrite production,
presumbly by providing new nutrients. This discrepancy may reflect differences
between macrophage cell lines and fresh peritoneal macrophages. For example,
macrophage cell lines can proliferate in vitro, while fresh peritoneal macrophages
cannot.
We also observed that a fibroblastic cell line, McCoy cells (a human and
mouse hybrid), was induced by IFN - 7 and LPS to synthesize nitrite (Figure 13). The
levels o f nitrite production in McCoy cells were tower than those in the macrophage
cell lines. Either IFN - 7 or LPS alone induced minimal nitrite production in McCoy
cells. Other cell types such as endothelial cells or hcpatocytcs also were reported to
synthesize nitrite (Moncada ct al. 1991). This indicated that not only macrophages but
a variety o f cell types synthesized nitrite in response to IFN - 7 and LPS.
CT infection alone was not sufficient to induce nitrite production in
RAW264.7 or McCoy cells. However, CT infection enhanced nitrite production
induced by IFN - 7 in these cells (Figures 15-16). This may be related to chlamydial
LPS since LPS has been found in infected cell membranes (Hearn and McNabb 1991)
and has been shown to function syncrgistically with IFN - 7 to induce nitrite synthesis.
However, BCG or PPD, which did not contain LPS, induced nitrite production in
RAW264.7 cells and peritoneal macrophages (Stuehr and Marietta 1987a-b).
Therefore, the possibility that CT infection itself primed the infected cells by an

117
undefined mcchanism(s) cannot be ruled out.

Correlation of Nitrite Production and CT Inhibition
A strong correlation between nitrite production and inhibition of CT replication
in RAW264.7 (correlation coefficient: -0.93, p < 0.001) or J774A.1 cells (correlation
coefficient: -0.94, p < 0.001) was observed (Figure 17A-B). This suggested that nitrite
production may be a mechanism for inhibition o f CT replication. The correlation
(correlation coefficient: -0.67, p < 0 .0 5 ) was observed in McCoy cells (Figure 17C).
However, the slope of the regression curve was smaller (0.522) than those o f the
macrophage cell lines (2.061-2.453). This indicated that CT replication in McCoy
cells was less affected by nitrite production than in the macrophage cell lines.

Inhibition of Nitrite Production and
Restoration of CT Replication bv L-NMMA
In order to demonstrate that nitrite production is the mechanism of inhibition
of CT replication, L-NMMA was employed to block nitrite production. L-NMMA
inhibited nitrite production in mouse macrophages and McCoy cells (Figures 19-21),
which is consistent with other reports (Mayer et al. 1993, Moncada ct al. 1991).
Concentrations o f L-NMMA varied (0.1-0.5 inM) from laboratory to laboratory
(Moncada et al. 1991, Mayer et al. 1993, Hibbs et al. 1987, Murray and Teitelbaum
1992, Lin and Chadee 1992). In our study, the inhibitory effect of L-NMMA was
proportional to the concentration used (Figure 18). However, inhibition of nitrite
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production was dependent not only upon concentration o f L-NMMA, but varied with
cell type and stimuli. For example, 1 mM L-NMMA completely inhibited nitrite
production in LPS-treated J774A.I (Figure 20A), but only 77% inhibition was
observed in LPS-treated RAW264.7 celts (Figure I9A). 10 mM L-NMMA completely
inhibited nitrite production in CT-infected RAW264.7 cells treated with either LPS or
IFN- 7 , but only 94% inhibition was observed in the cells treated with both IFN - 7 and
LPS (Figure 24).
LPS is a strong stimulus of TN F-a production in mouse macrophage cell lines
and peritoneal macrophages (Jue et al. 1990, Kelly et al. 1991, Martin and Dorf
1990, Lewis 1990). Therefore, T N F-a production was investigated in macrophage
cell lines. TN F-a production was higher in LPS-treated RAW264.7 cells (Figure 22)
than in the treated J774A.1 ceils (Figure 23). L-NMMA did not reduce TN F-a
production in these cells, which indicated that inhibition o f nitrite production by LNMMA was specific and that NO did not function as a regulatory molecule for TNFa production.
L-NMMA abrogated inhibition of CT replication in macrophage cell lines
(Figures 25, 27). The abrogation was dose-dependent. Restoration o f CT replication
induced by L-NMMA (5-10 mM) was 55 or 71% in RAW264.7 cells treated with
IFN - 7 or LPS, respectively. The restoration in LPS-treated J774A.1 cells (52%) was
comparable to that o f RAW264.7 cells (55%). However, the restoration induced by
L-NMMA was low ( < 10%) in J774A.1 cells treated with IFN - 7 or IFN - 7 plus LPS,
although CT recovery was increased remarkably (0.9 or 1.4 log | 0 units, respectively).

The reason for the lower level of restoration in J774A.I cells is unknown. Continuous
IL-1 secretion by J774A.1 cells was reported and secretion increased following
treatment with LPS (ATCC 1988, Martin and Dorf 1990, Lewis ct al. 1990). IL-1 has
been shown to inhibit CT replication in HEp-2 cells by PGE2 production (ShcmcrAvni et al. 1990). However, as discussed previously, it is unknown if J774A. 1 cells
responded to IL-1 by expressing antichlamydial activity. Furthermore, restoration of
CT replication induced by L-NMMA in LPS-treated J774A.1 cells was comparable to
that in RAW264.7 cells, indicating that IL-1 production may not be involved. These
results indicated (hat (a) nitrite production is one mechanism o f inhibition of CT
replication in the macrophage cell lines, but that (b) other mechanisms also may be
involved in RAW264.7 and J774A.1 cells. It is noteworthy that in the numerous
reports that have suggested a role for NO in antimicrobial activities exhibited by
activated mouse peritoneal macrophages or murine cell lines, the degree to which LNMMA or arginase reversed such activity has varied. Restoration o f microorganism
replication induced by L-NMMA or arginase has ranged from moderate to nearby
complete depending upon the test pathogens, the target cells and the cytokines
(Granger ct al. 1991, James and Glaven 1989, Liew et al. 1990a-c, Green et al.
1990a-b, 1991, Adams et al. 1990, Mauel et al. 1991, Bogdan et al. 1991, Denis
1991).
In McCoy cells, IFN-y inhibited CT replication but to a lesser extent than in
other cells treated with IFN-y. In contrast to other cells, LPS did not induce NO
production or inhibit CT replication in McCoy cells. L-NMMA (0,1 mM) remarkably
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inhibited nitrite production, but only slightly increased CT recovery by 0.16 or 0.28
logs IFU/ml in McCoy cells treated with IFN - 7 or IFN - 7 plus LPS (Figure 29). A
high concentration of L-NMMA (5 mM) did not increase CT recovery further.
Therefore, nitrite production probably is not the mechanism o f inhibition o f CT
replication in McCoy cells treated with IFN- 7 . However, Mayer et al. (1993) recently
reported that IFN- 7 -pretreated McCoy cells dramatically reduced CT (type H)
replication by 4 log,o units. L-NMMA reversed the inhibition. This discrepancy may
be due to differences in CT strains or McCoy cells (the McCoy cells used in our
laboratory arc a human-mousc hybrid, while McCoy cells used by Mayer ct al. were
a murine-derived cell line). Furthermore, alternate methods o f IFN - 7 treatment were
used in the two studies.
Since all evidence indicated that nitrite production is one o f the mechanisms o f
inhibition o f CT replication, it was necessary to determine if nitrite played an
essential role in this inhibition. Our data showed that exogenous nitrite (50-200
nmol/ml) did not affect CT replication in RAW264.7 cells (Figure 30), which
suggested that the mediator of nitrite production, rather than nitrite itself, functioned
as the effector molecule.

Correlation of NOS mRNA Expression with
CT Inhibition in RAW264.7 Cells
It has been demonstrated that immunological activation induces NOS at the
transcriptional level in RAW264.7 cells (Xie ct al. 1992). Few investigators
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determined NOS mRNA expression to confirm NO production as a mechanism for
antimicrobial or antitumoral activity. However, in this study, we determined NOS
mRNA expression (approximately 4.1 kb) in RAW264.7 cells by using Northern Blot
and Dot Blot hybridization. IFN - 7 or LPS induced significant NOS mRNA expression
in CT-infccted RAW264.7 cells (Figure 32, 33A, 34A). Combination o f IFN - 7 with
LPS exhibited a synergistic effect upon NOS mRNA expression. The peak of NOS
mRNA expression was 6-24 hours pt (Figure 32). No detectable NOS mRNA was
observed in untreated RAW264.7 cells. Similar results were observed in uninfected
RAW264.7 cells by Lowcnstcin et al. (1992). These results also were consistent with
nitrite production in cells treated with LPS and/or IFN-7 . A strong correlation
between NOS mRNA expression and inhibition of CT replication (correlation
coefficient: -0.97, p < 0 .0 5 ) was observed. This further supported the contention that
NO is a mechanism of inhibition o f CT replication.

Effect o f Anti-TNF-a Ab upon NOS mRNA Expression.
Nitrite Production and CT Replication
In vitro, a combination o f rIFN*y and iT N F-a synergistically induced nitrite
production in mouse peritoneal macrophages and McCoy cells (Ding et al. 1988,
Mayer et al. 1993). However, the effect of endogenuous T N F -a upon nitrite
production has not been defined. Anti-TNF-a antibody, which completely neutralized
biological activity of secreted TN F-a (Figure 36), inhibited neither NOS mRNA
expression (Figures 33A, 34A) nor nitrite production (Figure 37) in LPS- or IFN-7 -
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treated RAW264.7 cells. However, the antibody significantly inhibited nitrite
production in peritoneal macrophages (Figure 40). One possible explanation for this is
that the cell line did not respond to TN F-a by nitrite production, although it did
respond to secreted TN F-a by exerting antichlamydial activity (Figure 38). Recently,
two distinct TN F-a receptors (TNF-R1 and TNF-R2) have been demonstrated in
human and mouse systems (Tarlaglia and Goeddel 1992). Binding o f TN F-a to TNFR1 results in cytotoxicity and antiviral activity. However, binding o f T N F-a to TNFR2 results in thymocyte and CTL proliferation. Therefore, there may be different
receptors expressed on peritoneal macrophages and RAW264.7 cells. Different
receptors may not explain (his phenomenon, since the antibody recognized epitopes on
T N F -a rather than on receptors. Another possibility is that the membrane-associated
T N F -a was not neutralized by the antibody in RAW264.7 cells. In fact, secreted
T N F -a was derived from membrane-associated precursors in LPS-treated RAW264.7
cells (Jue et al. 1990). A substantial amount of TN F-a was detected on the treated
cell surface (Jue ct al. 1990). Since RAW264.7 cells were confluent in cultures, the
antibody may not be sufficient to block the activity of membrane-associated TN F-a in
these cells. However, peritoneal macrophages were not confluent in cultures.
Therefore, the membrane associated TN F-a was sufficiently neutralized by the
antibody.
L-NMMA inhibits nitrite production by competitive binding o f NOS (Moncada
et al. 1991). As expected, L-NMMA did not affect transcription o f NOS gene
(Figures 33A, 34A), although remarkable inhibition of nitrite production by L-
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NMMA was observed (Figure 37).
Restoration o f CT replication induced by L-NMMA (5-10 mM) was not
complete even in IFN-y-lreated RAW264.7 cells, although nitrite production was
almost completely inhibited (Figures 26-27). Furthermore, L-NMMA induced
comparable inhibition of nitrite production but restored less of CT replication in LPStreated than in IFN-y-treated RAW264.7 cells. The former produced high levels of
TN F-a which may be involved in the inhibition. rTN F-a has been shown to inhibit
CT replication in HEp-2 cells (Shcmcr-Avni et al, 1988, 1989). Treatment of McCoy
cells with iT N F-a post-inoculation significantly inhibited initial inclusion formation
and CT replication (Table 3). This treatment also caused atypical inclusions with less
glycogen than those in untreated cells (data not shown). The significance of this is
unknown although it has been suggested that glycogen deposition in CT inclusions is
not required for complete replication (Matsumolo 1988). The effect of secreted TNFa upon CT replication remains unclear. An anti-TNF-a neutralizing Ab was employed
to investigate this effect in RAW264.7 cells. The Ab, which completely neutralized
biological activity o f secreted TN F-a, neither inhibited nitrite production (Figure 37)
nor reversed inhibition of CT replication (Figure 38) in RAW264.7 cells treated with
LPS- and/or IFN-7 . Combination o f the Ab with L-NMMA significantly enhanced the
restoration of CT replication in the cells treated with LPS or IFN-y, particularly in
cells treated with LPS (Figure 38). These results indicated that (a) secreted TN F-a
may be involved in antichlamydial activity, but the mechanism may be distinct from
NO production; (b) the antichlamydial effect o f secreted TN F-a may be overwhelmed
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by NO production in the presence o f LPS or IFN-y.

Inhibition o f CT Replication in Peritoneal Macrophages
Wc have demonstrated that NO and TN F-a production arc involved in
inhibition of CT replication in LPS- or IFN-y-activalcd RAW264.7 cells. We now
wished to determine if the same mechanisms were operative in peritoneal
macrophages. TN F-a production was induced by LPS in peritoneal macrophages
(Figure 36). The level of TN F-a was much lower than in macrophage cell lines. This
may suggest that peritoneal macrophages and macrophage cell lines are at different
stages of activation. As in macrophage cell lines, high levels o f nitrite production
were induced in peritoneal macrophages by LPS or IFN-y (Figure 40) and nitrite
production was dramatically inhibited by L-NMMA (Figure 40). However, anti-TNFa antibody, which did not affect nitrite production in macrophage cell lines,
significantly inhibited nitrite production in peritoneal macrophages treated with LPS
and/or IFN-y (Figure 40). This indicated that secreted T N F -a may be an
autoregulatory cytokine for nitrite production during activation o f peritoneal
macrophages.
CT replication was dramatically inhibited in peritoneal macrophages treated
with IFN-y and/or LPS. However, the mechanism(s) of inhibition in peritoneal
macrophages may be different from that in the macrophage cell lines. Although LNMMA partially restored CT replication (34-35%) in the IFN-y-trcatcd peritoneal
macrophages, it did not reverse the inhibition in LPS-treated cells (Figure 41). This
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suggested that NO production may be a mechanism of CT inhibition in IFN-y-lreated
peritoneal macrophages, but may not be active in LPS-treated cells. Furthermore,
anti-TNF-a Ab significantly inhibited nitrite production and partially restored CT
replication (34-35%) in peritoneal macrophages treated with IFN-y. The latter
suggested that secreted TN F-a may exert antichlamydial activity by up-regulation of
the NO production pathway during activation o f peritoneal macrophages by IFN-y.
Neither Ab alone nor in combination with L-NMMA reversed CT inhibition in LPStreated cells, indicating that NO or TN F-a may not be the mechanism for inhibition
of CT replication in peritoneal macrophages activated by LPS.

Direct Effect of IFN-y and LPS upon CT Replication
In order to examine the direct effect of IFN-y and LPS upon CT replication,
two human epithelial cell lines OVCAR-3 and KLE were employed. These cell lines
did not respond to murine IFN-y and LPS by nitrite or TN F-a production (data not
shown). Treatment with IFN-y and LPS did not affect CT replication in these cells
(Figure 42). A direct inhibitory effect of IFN-y and LPS upon CT replication in
highly susceptible cells was thereby refuted. Since IFN-y used in this study was
murine recombinant and response to IFN-y is species specific, human IFN-y may
clicitc an effect upon CT replication in these cell lines.

Effect o f Tryptophan upon CT Replication
Tryptophan degradation has been reported to be a mechanism of inhibition of
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CT replication in IFN- 7 -treatcd human cell lines (HEp-2 and T24) or human
monocytes/ macrophages (Byrne et al. 1986, Murray et al. 1989), However, we
demonstrated that exogenous tryptophan (40 to 1000 *xg/ml) failed to reverse
inhibition of CT replication in IFN- 7 - and LPS-treated RAW264.7 cells (Figure 44),
In order to exclude the possibility that the effect o f tryptophan degradation might have
been overwhelmed by NO production, we treated the cells with exogenous tryptophan
and L-NMMA, The combination of exogenous tryptophan with L-NMMA did not
affect the inhibition (Figure 44), These results indicated that tryptophan degradation
may not be the mechanism o f inhibition in this macrophage cell line. Antichlamydial
effect without involvement o f tryptophan degradation in other murine-derived cell
lines also was reported by other investigators (Mayer et al, 1993, de la Maza et al.
1985, Murray ct al. 1989). Our data supported the hypothesis that the tryptophan
degradation mechanism is species-specific, i.e., involved in antichlamydial activity in
human cells, but not in murine cells.

Summary and Conclusions
In summary, IFN - 7 or LPS induced inhibition o f CT replication in peritoneal
macrophages and macrophage cell lines. In McCoy cells, only IFN - 7 inhibited CT
replication. L-NMMA (1 mM) inhibited nitrite production and restored CT replication
in RAW264.7 cells treated with IFN - 7 or LPS, Inhibition of nitrite production and
restoration of CT replication induced by L-NMMA was comparable in LPS-treated
J774A.1 cells and lFN- 7 -lreated peritoneal macrophages. However, L-NMMA (1
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mM) inhibited nitrite production but did not significantly restore CT replication in
LPS-treated pertoneai macrophages, IFN-7 -treatcd McCoy o r J774A.1 cells. AntiT N F -a antibody inhibited nitrite production in LPS- or IFN- 7 -trcatcd peritoneal
macrophages but restored CT replication only in IFN- 7 -trcated cells. In LPS- or IFN7

-treated RAW264.7 cells, anti-TNF-a antibody alone neither reduced nitrite

production nor restored CT replication. Combination of the antibody and L-NMMA
significantly enhanced restoration of CT replication without increase in inhibition of
nitrite production. Therefore, we have made the following conclusions: (1) NO
production is one o f the mechanisms for inhibition o f CT replication in IFN-7 activaled peritoneal macrophages and RAW264.7 cells; (2) NO plays a significant role
in CT inhibition in LPS-treated macrophage cell lines but not peritoneal macrophages;
(3) TN F-a may be associated with inhibition, but the mcchanism(s) may not involve
NO production; (4) NO production may not be the mechanism for CT inhibition in
McCoy cells treated with IFN-7 .
Macrophage activation induced by IFN - 7 or LPS is a complicated process
which involves many biological and biochemical events including receptor-ligand
binding, signal transduction, gene expression, cytokine secretion and feedback
regulation (Adams and Hamilton 1992). Although we demonstrated that NO and
secreted TN F-a arc involved in inhibition o f CT replication in peritoneal macrophages
and macrophage cell lines activated by IFN - 7 or LPS, the whole picture o f inhibition
in activated macrophages remains unclear. Complete understanding o f the interaction
between macrophages and CT would have a significant impact on elucidation o f the

immune response against CT infection as well as prevention of infection.
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